CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | aryl hydrocarbon receptor agonist |
|
Accession: | CHEBI:72768
|
browse the term
|
Definition: | An agonist that binds to and activates aryl hydrocarbon receptors (AhRs). |
Synonyms: | related_synonym: | AHR agonist; AhR agonists; aryl hydrocarbon receptor agonists |
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions affects localization |
ISO |
1,2-naphthoquinone promotes the reaction [AHR protein binds to ARNT protein]; 1,2-naphthoquinone promotes the reaction [AHR protein binds to CYP1A1 enhancer]; AHR protein affects the reaction [1,2-naphthoquinone results in increased expression of CYP1A1 mRNA] 1,2-naphthoquinone results in increased expression of and affects the localization of AHR protein 1,2-naphthoquinone affects the localization of AHR protein |
CTD |
PMID:26558468 PMID:27853106 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Akr1a1 |
aldo-keto reductase family 1 member A1 |
increases reduction |
ISO |
AKR1A1 protein results in increased reduction of 1,2-naphthoquinone |
CTD |
PMID:10510318 |
|
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B1 |
increases reduction |
ISO |
AKR1B1 protein results in increased reduction of 1,2-naphthoquinone |
CTD |
PMID:10510318 |
|
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
|
|
G |
Akr7a2 |
aldo-keto reductase family 7, member A2 |
increases reduction |
ISO |
AKR7A2 protein results in increased reduction of 1,2-naphthoquinone |
CTD |
PMID:10510318 |
|
NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909
|
|
G |
Alb |
albumin |
affects binding |
ISO |
1,2-naphthoquinone binds to ALB protein |
CTD |
PMID:12385719 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
increases expression |
ISO |
1,2-naphthoquinone results in increased expression of ALDH3A1 mRNA |
CTD |
PMID:26558468 |
|
NCBI chr10:45,892,993...45,902,680
Ensembl chr10:45,892,924...45,902,681
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
multiple interactions |
ISO |
1,2-naphthoquinone promotes the reaction [AHR protein binds to ARNT protein] |
CTD |
PMID:26558468 PMID:27853106 |
|
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
|
|
G |
Cat |
catalase |
multiple interactions |
ISO |
CAT protein inhibits the reaction [1,2-naphthoquinone results in increased expression of CXCL8 mRNA]; CAT protein inhibits the reaction [1,2-naphthoquinone results in increased expression of PTGS2 mRNA]; CAT protein promotes the reaction [1,2-naphthoquinone results in increased expression of HMOX1 mRNA] |
CTD |
PMID:21997482 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cbr1 |
carbonyl reductase 1 |
multiple interactions |
ISO |
[S-Nitrosoglutathione binds to CBR1 protein] promotes the reaction [CBR1 protein results in increased metabolism of 1,2-naphthoquinone] |
CTD |
PMID:23295225 |
|
NCBI chr11:32,860,571...32,862,981
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions |
ISO |
1,2-naphthoquinone binds to and results in decreased activity of CREB1 protein |
CTD |
PMID:21530497 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases expression |
ISO |
1,2-naphthoquinone promotes the reaction [AHR protein binds to CYP1A1 enhancer]; 1,2-naphthoquinone promotes the reaction [POLR2A protein binds to CYP1A1 protein]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [1,2-naphthoquinone results in increased expression of CYP1A1 mRNA]; AHR protein affects the reaction [1,2-naphthoquinone results in increased expression of CYP1A1 mRNA] |
CTD |
PMID:26558468 PMID:26656082 PMID:27853106 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Dcxr |
dicarbonyl and L-xylulose reductase |
increases metabolic processing multiple interactions |
ISO |
DCXR protein results in increased metabolism of 1,2-naphthoquinone 1,2-naphthoquinone inhibits the reaction [[[DCXR protein co-treated with NAD] results in increased reduction of Diacetyl] which results in increased chemical synthesis of Acetoin] |
CTD |
PMID:28595002 |
|
NCBI chr10:106,006,404...106,008,293
|
|
G |
Dhrs7 |
dehydrogenase/reductase 7 |
increases reduction |
ISO |
DHRS7 protein results in increased reduction of 1,2-naphthoquinone |
CTD |
PMID:24246760 |
|
NCBI chr 6:91,332,259...91,347,856
Ensembl chr 6:91,251,323...91,347,892
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions increases phosphorylation |
ISO |
1,2-naphthoquinone results in increased phosphorylation of and results in increased activity of EGFR protein; 1,4-naphthoquinone promotes the reaction [1,2-naphthoquinone results in increased phosphorylation of EGFR protein]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [1,4-naphthoquinone promotes the reaction [1,2-naphthoquinone results in increased phosphorylation of EGFR protein]] |
CTD |
PMID:24067727 PMID:33814511 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases stability |
ISO |
1,2-naphthoquinone results in increased stability of FOS protein |
CTD |
PMID:24067727 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
decreases activity affects binding multiple interactions |
ISO |
1,2-naphthoquinone results in decreased activity of GAPDH protein 1,2-naphthoquinone binds to GAPDH protein [Buthionine Sulfoximine results in decreased abundance of Glutathione] promotes the reaction [1,2-naphthoquinone binds to GAPDH protein]; [Buthionine Sulfoximine results in decreased abundance of Glutathione] promotes the reaction [1,2-naphthoquinone results in decreased activity of GAPDH protein] |
CTD |
PMID:21827172 |
|
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression |
ISO |
CAT protein promotes the reaction [1,2-naphthoquinone results in increased expression of HMOX1 mRNA] |
CTD |
PMID:21997482 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
multiple interactions |
ISO |
1,2-naphthoquinone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased activity of IKBKB protein] |
CTD |
PMID:21139339 |
|
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
affects response to substance increases metabolic processing |
ISO |
KEAP1 protein affects the susceptibility to 1,2-naphthoquinone 1,2-naphthoquinone results in increased metabolism of KEAP1 protein |
CTD |
PMID:21384861 PMID:25807370 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases phosphorylation |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [1,2-naphthoquinone results in increased phosphorylation of MAPK1 protein]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [1,2-naphthoquinone results in increased phosphorylation of MAPK1 protein]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [[1,2-naphthoquinone co-treated with 1,4-naphthoquinone] results in increased phosphorylation of MAPK1 protein]; [1,2-naphthoquinone co-treated with 1,4-naphthoquinone] results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:24067727 PMID:33814511 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation multiple interactions |
ISO |
1,2-naphthoquinone results in increased phosphorylation of MAPK3 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [1,2-naphthoquinone results in increased phosphorylation of MAPK3 protein]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [1,2-naphthoquinone results in increased phosphorylation of MAPK3 protein]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [[1,2-naphthoquinone co-treated with 1,4-naphthoquinone] results in increased phosphorylation of MAPK3 protein]; [1,2-naphthoquinone co-treated with 1,4-naphthoquinone] results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:24067727 PMID:33814511 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions increases activity affects response to substance |
ISO |
NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to 1,2-naphthoquinone] 1,2-naphthoquinone results in increased activity of NFE2L2 protein [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to 1,2-naphthoquinone; NFE2L2 protein affects the susceptibility to 1,2-naphthoquinone |
CTD |
PMID:19303893 PMID:20932822 PMID:21384861 PMID:21651925 PMID:25807370 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
1,2-naphthoquinone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased phosphorylation of and results in increased degradation of NFKBIA protein] |
CTD |
PMID:21139339 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
1,2-naphthoquinone inhibits the reaction [[lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide] |
CTD |
PMID:21139339 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases reduction increases expression |
ISO |
NQO1 protein results in increased reduction of 1,2-naphthoquinone 1,2-naphthoquinone results in increased expression of NQO1 mRNA |
CTD |
PMID:21384861 PMID:26558468 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Polr2a |
RNA polymerase II subunit A |
multiple interactions |
ISO |
1,2-naphthoquinone promotes the reaction [POLR2A protein binds to CYP1A1 protein] |
CTD |
PMID:26558468 |
|
NCBI chr10:54,452,438...54,478,486
Ensembl chr10:54,452,441...54,478,455
|
|
G |
Prdx6 |
peroxiredoxin 6 |
multiple interactions |
ISO |
1,2-naphthoquinone binds to and results in decreased activity of PRDX6 protein |
CTD |
PMID:22129745 |
|
NCBI chr13:73,528,746...73,539,295
Ensembl chr13:73,528,210...73,539,355
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression multiple interactions |
ISO |
1,2-naphthoquinone results in increased expression of PTGS2 mRNA CAT protein inhibits the reaction [1,2-naphthoquinone results in increased expression of PTGS2 mRNA] |
CTD |
PMID:21997482 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptpn1 |
protein tyrosine phosphatase, non-receptor type 1 |
decreases activity multiple interactions |
ISO |
1,2-naphthoquinone results in decreased activity of PTPN1 protein 1,2-naphthoquinone promotes the reaction [1,4-naphthoquinone results in increased metabolism of and results in decreased activity of PTPN1 protein] |
CTD |
PMID:24067727 PMID:33814511 |
|
NCBI chr 3:156,638,811...156,687,503
Ensembl chr 3:156,638,769...156,687,504
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
1,2-naphthoquinone inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased localization of and results in increased activity of RELA protein] |
CTD |
PMID:21139339 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Tacr1 |
tachykinin receptor 1 |
multiple interactions |
EXP |
[1,2-naphthoquinone co-treated with Vehicle Emissions] results in increased expression of TACR1 mRNA; Capsaicin inhibits the reaction [[1,2-naphthoquinone co-treated with Vehicle Emissions] results in increased expression of TACR1 mRNA] |
CTD |
PMID:19399481 |
|
NCBI chr 4:114,920,844...115,089,733
Ensembl chr 4:114,920,844...115,089,733
|
|
G |
Tacr2 |
tachykinin receptor 2 |
multiple interactions |
EXP |
[1,2-naphthoquinone co-treated with Vehicle Emissions] results in increased expression of TACR2 mRNA; Capsaicin inhibits the reaction [[1,2-naphthoquinone co-treated with Vehicle Emissions] results in increased expression of TACR2 mRNA] |
CTD |
PMID:19399481 |
|
NCBI chr20:30,208,907...30,223,446
Ensembl chr20:30,208,907...30,223,446
|
|
G |
Top2a |
DNA topoisomerase II alpha |
multiple interactions affects activity |
ISO |
1,2-naphthoquinone binds to and results in decreased activity of TOP2A protein 1,2-naphthoquinone affects the activity of TOP2A protein |
CTD |
PMID:22218491 PMID:33760604 |
|
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
|
|
G |
Top2b |
DNA topoisomerase II beta |
affects activity |
ISO |
1,2-naphthoquinone affects the activity of TOP2B protein |
CTD |
PMID:33760604 |
|
NCBI chr15:9,051,340...9,111,721
Ensembl chr15:9,051,341...9,112,085
|
|
G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
increases activity |
ISO |
1,2-naphthoquinone results in increased activity of TRPA1 protein |
CTD |
PMID:21591660 |
|
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
|
|
G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
multiple interactions |
EXP |
[1,2-naphthoquinone co-treated with Vehicle Emissions] results in increased expression of TRPV1 mRNA; Capsaicin inhibits the reaction [[1,2-naphthoquinone co-treated with Vehicle Emissions] results in increased expression of TRPV1 mRNA] |
CTD |
PMID:19399481 |
|
NCBI chr10:57,851,428...57,876,513
Ensembl chr10:57,851,428...57,876,513
|
|
G |
Trpv3 |
transient receptor potential cation channel, subfamily V, member 3 |
increases activity |
ISO |
1,2-naphthoquinone results in increased activity of TRPV3 protein |
CTD |
PMID:29658714 |
|
NCBI chr10:57,883,546...57,915,865
Ensembl chr10:57,883,546...57,913,296
|
|
G |
Uchl1 |
ubiquitin C-terminal hydrolase L1 |
multiple interactions |
ISO |
1,2-naphthoquinone results in increased metabolism of and results in decreased activity of UCHL1 protein; Glutathione inhibits the reaction [1,2-naphthoquinone results in increased metabolism of and results in decreased activity of UCHL1 protein] |
CTD |
PMID:24582816 |
|
NCBI chr14:41,485,031...41,495,590
Ensembl chr14:41,485,031...41,495,590
|
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of ABCA1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ABCB1 mRNA; Methylcholanthrene results in increased expression of ABCB1A mRNA |
CTD |
PMID:11096091 PMID:27160211 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
increases expression multiple interactions |
ISO |
Methylcholanthrene results in increased expression of ABCB1B mRNA Methylcholanthrene promotes the reaction [TRP53 protein binds to ABCB1B promoter] |
CTD |
PMID:11096091 PMID:20713471 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of ABCB4 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
|
|
G |
Abcb6 |
ATP binding cassette subfamily B member 6 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ABCB6 mRNA |
CTD |
PMID:22761424 |
|
NCBI chr 9:76,668,554...76,677,263
Ensembl chr 9:76,668,554...76,676,924
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
increases expression |
EXP |
Methylcholanthrene results in increased expression of ABCC3 mRNA |
CTD |
PMID:19118567 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ABCC4 mRNA; Methylcholanthrene results in increased expression of ABCC4 protein |
CTD |
PMID:20395535 |
|
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
multiple interactions increases expression affects response to substance |
ISO |
AHR protein affects the reaction [Methylcholanthrene results in increased expression of ABCG2 mRNA]; Methylcholanthrene promotes the reaction [AHR protein binds to ABCG2 5' UTR] Methylcholanthrene results in increased expression of ABCG2; Methylcholanthrene results in increased expression of ABCG2 mRNA; Methylcholanthrene results in increased expression of ABCG2 mRNA alternative form; Methylcholanthrene results in increased expression of ABCG2 protein ABCG2 5' UTR affects the susceptibility to Methylcholanthrene |
CTD |
PMID:20804740 PMID:23081912 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Abi3bp |
ABI family member 3 binding protein |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of ABI3BP mRNA |
CTD |
PMID:20713471 |
|
NCBI chr11:43,912,187...44,128,888
Ensembl chr11:43,913,043...44,128,929
|
|
G |
Acox2 |
acyl-CoA oxidase 2 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to ACOX2 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr15:16,660,584...16,692,160
Ensembl chr15:16,660,272...16,692,160
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to ACSL4 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
|
|
G |
Acta1 |
actin, alpha 1, skeletal muscle |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of ACTA1 mRNA |
CTD |
PMID:29554273 |
|
NCBI chr19:51,883,709...51,886,735
Ensembl chr19:51,883,715...51,886,742
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of ACTA2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Adam8 |
ADAM metallopeptidase domain 8 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ADAM8 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801
|
|
G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
decreases acetylation increases methylation multiple interactions increases expression |
EXP |
Methylcholanthrene results in decreased acetylation of ADAMTS1 promoter Methylcholanthrene results in increased methylation of ADAMTS1 promoter [alpha-naphthoflavone co-treated with Methylcholanthrene] results in decreased acetylation of ADAMTS1 promoter; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased acetylation of ADAMTS1 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased expression of ADAMTS1 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of ADAMTS1 promoter] Methylcholanthrene results in increased expression of ADAMTS1 mRNA |
CTD |
PMID:29094188 |
|
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
|
|
G |
Adamts12 |
ADAM metallopeptidase with thrombospondin type 1 motif, 12 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of ADAMTS12 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 2:60,032,873...60,327,629
Ensembl chr 2:60,032,873...60,327,629
|
|
G |
Adamts2 |
ADAM metallopeptidase with thrombospondin type 1 motif, 2 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of ADAMTS2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr10:34,920,992...35,126,465
Ensembl chr10:34,921,049...35,123,821
|
|
G |
Adamts4 |
ADAM metallopeptidase with thrombospondin type 1 motif, 4 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ADAMTS4 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr13:83,670,556...83,680,045
Ensembl chr13:83,670,183...83,680,065
|
|
G |
Adcy7 |
adenylate cyclase 7 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ADCY7 mRNA |
CTD |
PMID:20713471 PMID:29554273 |
|
NCBI chr19:18,740,875...18,798,924
Ensembl chr19:18,740,875...18,776,311
|
|
G |
Adgrf1 |
adhesion G protein-coupled receptor F1 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to ADGRF1 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 9:17,661,258...17,696,359
Ensembl chr 9:17,660,930...17,711,704
|
|
G |
Adgrg5 |
adhesion G protein-coupled receptor G5 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of ADGRG5 mRNA; [Methylcholanthrene co-treated with Nanotubes, Carbon] results in increased expression of ADGRG5 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr19:10,074,787...10,098,640
Ensembl chr19:10,079,375...10,097,214
|
|
G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of ADH4 mRNA |
CTD |
PMID:27055685 |
|
NCBI chr 2:226,948,717...226,966,747
Ensembl chr 2:226,947,466...226,987,591
|
|
G |
Adh6 |
alcohol dehydrogenase 6 (class V) |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of ADH6 mRNA |
CTD |
PMID:27055685 |
|
NCBI chr 2:226,903,208...226,934,564
Ensembl chr 2:226,903,250...226,934,534
|
|
G |
Adh7 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ADH7 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 2:226,748,724...226,763,183
Ensembl chr 2:226,741,788...226,763,182
|
|
G |
Adora2a |
adenosine A2a receptor |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of ADORA2A mRNA |
CTD |
PMID:23519560 |
|
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
|
|
G |
Adora3 |
adenosine A3 receptor |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of ADORA3 mRNA |
CTD |
PMID:23519560 |
|
NCBI chr 2:193,352,759...193,392,946
Ensembl chr 2:193,388,713...193,392,357
|
|
G |
Adra2a |
adrenoceptor alpha 2A |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to ADRA2A promoter] [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of ADRA2A mRNA |
CTD |
PMID:20348232 PMID:23519560 |
|
NCBI chr 1:253,061,480...253,064,280
Ensembl chr 1:253,060,218...253,064,365
|
|
G |
Agr2 |
anterior gradient 2, protein disulphide isomerase family member |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to AGR2 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 6:52,708,602...52,729,378
Ensembl chr 6:52,708,602...52,729,371
|
|
G |
Ahr |
aryl hydrocarbon receptor |
increases response to substance increases expression decreases expression affects binding multiple interactions increases activity increases localization affects response to substance increases degradation affects localization |
ISO EXP |
AHR protein results in increased susceptibility to Methylcholanthrene; AHR results in increased susceptibility to Methylcholanthrene Methylcholanthrene results in increased expression of AHR mRNA Methylcholanthrene results in decreased expression of AHR protein Methylcholanthrene binds to AHR protein [Genistein co-treated with Methylcholanthrene] affects the activity of AHR protein; AHR protein affects the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; AHR protein promotes the reaction [Methylcholanthrene results in increased expression of and results in increased activity of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to BAX promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to CASP9 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to CDK2 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to DNAJB6 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to HES1 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to ICAM1 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to IGF2 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to JAG1 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to SP1 promoter]]; Methylcholanthrene inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein]; Methylcholanthrene promotes the reaction [AHR protein binds to BAX promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CASP9 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CDK2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to DNAJB6 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to HES1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to ICAM1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to IGF2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to JAG1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to SP1 promoter] [Methylcholanthrene binds to and affects the localization of AHR protein] promotes the reaction [[AHR protein binds to CYP1A1 enhancer] which results in increased expression of CYP1A1 mRNA]; [Methylcholanthrene binds to and affects the localization of AHR protein] which results in increased expression of CYP1A1 mRNA; [Methylcholanthrene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA; [Methylcholanthrene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A2 mRNA; AHR affects the reaction [Methylcholanthrene results in increased activity of and results in increased expression of CYP1A1 protein]; AHR affects the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; AHR gene mutant form inhibits the reaction [Methylcholanthrene results in decreased expression of CYP3A11 mRNA]; AHR protein affects the reaction [Methylcholanthrene affects the expression of CYP1A1 mRNA]; AHR protein affects the reaction [Methylcholanthrene results in increased expression of FMO3 mRNA]; AHR protein promotes the reaction [Methylcholanthrene results in decreased expression of KNG1 mRNA]; AHR protein promotes the reaction [Methylcholanthrene results in decreased expression of KNG1 protein]; AHR protein promotes the reaction [Methylcholanthrene results in increased activity of CRYZ protein]; AHR protein promotes the reaction [Methylcholanthrene results in increased activity of XDH protein]; AHR protein promotes the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; AHR protein promotes the reaction [Methylcholanthrene results in increased expression of CYP1A1 protein]; AHR protein promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA]; AHR protein promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 protein]; Capsaicin inhibits the reaction [Methylcholanthrene results in increased activity of and results in increased localization of AHR protein]; CTNNB1 protein affects the reaction [[Methylcholanthrene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; Curcumin inhibits the reaction [Methylcholanthrene binds to AHR protein]; Cycloheximide promotes the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to CYP1A1 enhancer]]; Methylcholanthrene binds to and affects the localization of AHR protein; Methylcholanthrene binds to and results in increased activity of AHR protein; Methylcholanthrene inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein]; Methylcholanthrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [SRC protein binds to AHR protein]]; Methylcholanthrene promotes the reaction [AHR protein binds to CYP1A1 enhancer]; Methylcholanthrene promotes the reaction [AHR protein binds to CYP1A1 promoter]; Methylcholanthrene results in increased activity of and results in increased localization of AHR protein; omeprazole sulfide inhibits the reaction [Methylcholanthrene results in increased activity of AHR protein]; Raloxifene Hydrochloride inhibits the reaction [Methylcholanthrene binds to AHR protein] Methylcholanthrene results in increased localization of AHR protein AHR affects the susceptibility to Methylcholanthrene Methylcholanthrene results in increased degradation of AHR protein Methylcholanthrene results in increased expression of AHR protein [AHR gene mutant form binds to ARNT protein] which results in decreased susceptibility to Methylcholanthrene; [chrysin co-treated with Methylcholanthrene] affects the activity of AHR protein; [Genistein co-treated with Methylcholanthrene] affects the activity of AHR protein; [Methylcholanthrene co-treated with Oxygen deficiency] results in increased expression of AHR mRNA; [Methylcholanthrene co-treated with pirinixic acid] results in increased expression of AHR protein; [Methylcholanthrene results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA; [Methylcholanthrene results in increased activity of AHR protein] which results in increased expression of IL1B mRNA; [Quercetin co-treated with Methylcholanthrene] affects the activity of AHR protein; AHR gene mutant form inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; AHR protein affects the reaction [Methylcholanthrene results in increased expression of ABCG2 mRNA]; AHR protein affects the reaction [Methylcholanthrene results in increased expression of CYP3A5 mRNA]; AHR protein affects the reaction [Methylcholanthrene results in increased expression of MT2A mRNA]; AHR protein affects the susceptibility to [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; AHR protein affects the susceptibility to [Methylcholanthrene results in increased expression of CYP1A2 mRNA]; AHR protein promotes the reaction [Methylcholanthrene results in increased activity of CYP1A1 protein]; AHR protein promotes the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; AHR protein promotes the reaction [Methylcholanthrene results in increased expression of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased activity of AHR protein]; Methylcholanthrene binds to and results in increased activity of AHR protein; Methylcholanthrene binds to and results in increased activity of AHR protein polymorphism; Methylcholanthrene promotes the reaction [[AHR protein binds to ARNT protein] which binds to CYP1A1 enhancer]; Methylcholanthrene promotes the reaction [[AHR protein binds to ARNT protein] which results in increased expression of CYP1A1 mRNA]; Methylcholanthrene promotes the reaction [AHR protein binds to ABCG2 5' UTR]; Methylcholanthrene promotes the reaction [AHR protein binds to ACOX2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to ACSL4 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to ADGRF1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to ADRA2A promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to AGR2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to AKAP13 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to ANGPTL2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to ANKRD13C promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to ANKRD30B promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to ARHGAP22 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to ARHGAP35 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to ARHGAP44 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to ARL3 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to ARMC12 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to BAMBI promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to BBX promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to BCL6 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to BPIFA2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to BRCA1 protein]; Methylcholanthrene promotes the reaction [AHR protein binds to BRWD1-AS2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to C16ORF74 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to C4ORF19 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to C4ORF36 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CA12 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CA8 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CACNA1B promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CALB2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CAST promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CCDC144NL promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CCDC57 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CCDC6 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CCN5 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CCNG2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CD55 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CEACAM3 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CENPL promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CEP70 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CFAP61 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CHPT1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CHRDL2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CILK1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CISD1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CLDN17 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CLK3 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CLPSL2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to COLCA1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to COX4I1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CRKL promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CTNNA1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CUEDC1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CYB5B promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CYP1A1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CYP1B1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CYP2A7 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to DEGS1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to DIAPH1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to DTNA promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to DUSP14 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to EHD3 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to EPS15 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to ERCC6 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to ESR1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to EXOSC9 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to FOXN1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to FOXN4 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to FREM2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to GDPD4 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to GPHB5 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to GREB1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to GRIK4 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to GSDMC promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to H2BC1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to H2BC21 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to HCRTR2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to HDAC11 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to HOXC11 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to HSBP1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to IDH2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to IER3 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to IGFBPL1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to INHBC promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to IRF2BPL promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to ISOC2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to ITPR1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to JPH1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to KATNAL2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to KCTD16 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to KCTD3 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to KIR2DL4 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to KLF9 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to KRT75 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to LGALS8 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to LGI1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to LIF promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to LIMA1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to LINC00173 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to LRP11 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to LSM5 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to LY6E promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to MAPKAP1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to MBNL1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to MED13L promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to MESP1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to MGST2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to MIDEAS promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to MLLT6 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to MLPH promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to MPI promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to MRTFB promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to MS4A7 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to MSMB promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to MTCL3 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to MYOF promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to MYOM2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to NBPF10 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to NBPF3 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to NDST1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to NELFCD promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to NFE2L2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to NMRAL1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to NXT2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to OSBPL10 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to OTUB2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to PAXBP1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to PCOLCE2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to PDCD4 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to PHACTR1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to PIGP promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to PIK3R1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to PLEKHA6 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to POGZ promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to POTEB promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to PPIAL4A promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to PRKAB1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to PRKAB2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to PRPS1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to PSG5 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to PSG9 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to PWWP3A promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to RABL2A promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to RALGAPA2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to RANBP2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to RBBP7 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to RBM24 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to RBMS2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to RBSN promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to RERG promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to RFFL promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to RGPD5 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to RGPD6 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to RGS3 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to RHOBTB1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to RHOH promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to RPL11 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to RTN3 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to RYR3 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to S100P promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to SAMD12 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to SCN3B promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to SIK3 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to SLC16A6 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to SLC22A23 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to SLC44A1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to SLU7 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to SMAP2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to SMARCE1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to SNAPIN promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to SOCS7 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to SORL1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to SOS1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to SPON2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to SPRED1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to SPTLC2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to SS18 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to STARD13 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to STAT5B promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to SWSAP1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to SYCP2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to SYT12 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to TBL1XR1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to TEAD4 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to THBS2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to THEM5 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to TIPARP promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to TMEM116 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to TMEM30A promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to TMEM45B promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to TMEM97 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to TMTC2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to TNK2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to TRERF1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to TRIM39 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to TRIM55 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to TRIM72 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to TRPV4 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to TTC3 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to UBE2E1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to UMODL1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to VEZT promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to VIPR1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to VSTM1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to VWCE promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to WBP1L promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to WDR26 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to WEE1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to ZBTB4 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to ZCCHC2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to ZMAT3 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to ZMIZ1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to ZNF281 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to ZNF552 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to ZNF587 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to ZNF695 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to ZNF710 promoter]; Methylcholanthrene promotes the reaction [Nicardipine results in increased activity of AHR protein]; Methylcholanthrene results in increased activity of and results in increased degradation of AHR protein; Nicardipine promotes the reaction [Methylcholanthrene results in increased activity of AHR protein]; omeprazole sulfide inhibits the reaction [Methylcholanthrene results in increased activity of AHR protein]; Resveratrol inhibits the reaction [Methylcholanthrene results in increased activity of AHR protein] Methylcholanthrene affects the localization of AHR protein |
CTD |
PMID:1650214 PMID:1654865 PMID:1658612 PMID:1846074 PMID:2154949 PMID:2833345 PMID:3005314 PMID:3024361 PMID:3040233 PMID:3402044 PMID:6301823 PMID:6322977 PMID:6749129 PMID:7140758 PMID:8163516 PMID:8163517 PMID:8937476 PMID:11158718 PMID:11243847 PMID:11285323 PMID:11339718 PMID:11549291 PMID:11768231 PMID:12117779 PMID:12490138 PMID:12700417 PMID:12825898 PMID:14993811 PMID:15297030 PMID:15585370 PMID:15860653 PMID:16109480 PMID:16137816 PMID:16359657 PMID:16489053 PMID:16829687 PMID:17069994 PMID:17880909 PMID:18022818 PMID:18259752 PMID:18835618 PMID:19286049 PMID:19853001 PMID:19951702 PMID:20067464 PMID:20171196 PMID:20348232 PMID:20540524 PMID:20570689 PMID:20570779 PMID:20804740 PMID:20881032 PMID:21250977 PMID:21292640 PMID:21498875 PMID:21666223 PMID:21756928 PMID:23273579 PMID:23712962 PMID:23846873 PMID:23994556 PMID:24481452 PMID:24486526 PMID:26006071 PMID:27644595 PMID:28887089 PMID:29094188 PMID:33408298 PMID:33811995 More...
|
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Ahrr |
aryl-hydrocarbon receptor repressor |
multiple interactions increases expression |
ISO |
[Tetradecanoylphorbol Acetate co-treated with Methylcholanthrene] results in increased expression of AHRR mRNA Methylcholanthrene results in increased expression of AHRR mRNA |
CTD |
PMID:9887096 PMID:11423533 PMID:12655030 PMID:14672759 |
|
NCBI chr 1:28,993,634...29,088,673
Ensembl chr 1:28,993,634...29,088,673
|
|
G |
Akap13 |
A-kinase anchoring protein 13 |
decreases expression multiple interactions |
ISO |
Methylcholanthrene results in decreased expression of AKAP13 mRNA Methylcholanthrene promotes the reaction [AHR protein binds to AKAP13 promoter] |
CTD |
PMID:20348232 PMID:20713471 |
|
NCBI chr 1:129,313,183...129,619,647
Ensembl chr 1:129,314,402...129,619,646
|
|
G |
Akr1a1 |
aldo-keto reductase family 1 member A1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of AKR1A1 mRNA |
CTD |
PMID:9973208 |
|
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of AKR1C1 mRNA |
CTD |
PMID:9973208 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions decreases acetylation increases expression |
EXP |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased acetylation of AKT1 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of AKT1 mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alcam |
activated leukocyte cell adhesion molecule |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ALCAM mRNA |
CTD |
PMID:20713471 |
|
NCBI chr11:48,336,123...48,536,296
Ensembl chr11:48,336,169...48,537,954
|
|
G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
increases expression |
ISO EXP |
Methylcholanthrene results in increased expression of ALDH3A1 mRNA |
CTD |
PMID:1416978 PMID:20713471 PMID:28601433 |
|
NCBI chr10:45,892,993...45,902,680
Ensembl chr10:45,892,924...45,902,681
|
|
G |
Angptl2 |
angiopoietin-like 2 |
increases expression multiple interactions |
ISO |
Methylcholanthrene results in increased expression of ANGPTL2 mRNA Methylcholanthrene promotes the reaction [AHR protein binds to ANGPTL2 promoter] |
CTD |
PMID:20348232 PMID:20713471 |
|
NCBI chr 3:16,517,185...16,547,024
Ensembl chr 3:16,517,420...16,548,178
|
|
G |
Ank2 |
ankyrin 2 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of ANK2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 2:215,378,028...215,954,015
Ensembl chr 2:215,379,680...215,862,923
|
|
G |
Ankh |
ANKH inorganic pyrophosphate transport regulator |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ANK mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 2:78,153,027...78,280,181
Ensembl chr 2:78,153,026...78,280,187
|
|
G |
Ankrd13c |
ankyrin repeat domain 13C |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to ANKRD13C promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 2:247,023,040...247,070,433
Ensembl chr 2:247,022,286...247,070,433
|
|
G |
Anln |
anillin, actin binding protein |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ANLN mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 8:20,858,227...20,921,602
Ensembl chr 8:20,858,228...20,921,538
|
|
G |
Anxa8 |
annexin A8 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ANXA8 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr16:9,397,144...9,412,072
Ensembl chr16:9,397,113...9,412,043
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
increases expression |
EXP |
Methylcholanthrene results in increased expression of APAF1 mRNA |
CTD |
PMID:23273579 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Apcdd1 |
APC down-regulated 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of APCDD1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr18:56,385,398...56,416,065
Ensembl chr18:56,385,264...56,416,070
|
|
G |
Apoa4 |
apolipoprotein A4 |
decreases expression |
EXP |
Methylcholanthrene results in decreased expression of APOA4 mRNA |
CTD |
PMID:11328961 |
|
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
|
|
G |
Apoc1 |
apolipoprotein C1 |
decreases expression |
EXP |
Methylcholanthrene results in decreased expression of APOC1 mRNA |
CTD |
PMID:11328961 |
|
NCBI chr 1:79,347,057...79,350,340
Ensembl chr 1:79,346,136...79,350,375
|
|
G |
Apod |
apolipoprotein D |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of APOD mRNA |
CTD |
PMID:20713471 |
|
NCBI chr11:69,431,261...69,452,306
Ensembl chr11:69,431,260...69,452,305
|
|
G |
Aqp5 |
aquaporin 5 |
increases expression |
ISO EXP |
Methylcholanthrene results in increased expression of AQP5 mRNA |
CTD |
PMID:20713471 PMID:26372666 |
|
NCBI chr 7:130,722,675...130,726,207
Ensembl chr 7:130,721,748...130,726,209
|
|
G |
Areg |
amphiregulin |
increases expression |
ISO EXP |
Methylcholanthrene results in increased expression of AREG mRNA |
CTD |
PMID:16257430 PMID:26372666 |
|
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
|
|
G |
Arhgap11a |
Rho GTPase activating protein 11A |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ARHGAP11A mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 3:100,590,865...100,607,146
Ensembl chr 3:100,590,865...100,607,559
|
|
G |
Arhgap22 |
Rho GTPase activating protein 22 |
increases expression multiple interactions |
ISO |
Methylcholanthrene results in increased expression of ARHGAP22 mRNA Methylcholanthrene promotes the reaction [AHR protein binds to ARHGAP22 promoter] |
CTD |
PMID:20348232 PMID:20713471 |
|
NCBI chr16:8,473,806...8,631,552
Ensembl chr16:8,476,306...8,631,548
|
|
G |
Arhgap35 |
Rho GTPase activating protein 35 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to ARHGAP35 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 1:77,202,436...77,319,298
Ensembl chr 1:77,202,436...77,319,298
|
|
G |
Arhgap44 |
Rho GTPase activating protein 44 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to ARHGAP44 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr10:49,655,583...49,822,876
Ensembl chr10:49,655,584...49,824,297
|
|
G |
Arl3 |
ADP ribosylation factor like GTPase 3 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to ARL3 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 1:245,400,659...245,446,673
Ensembl chr 1:245,400,550...245,446,820
|
|
G |
Arl6ip5 |
ADP-ribosylation factor like GTPase 6 interacting protein 5 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ARL6IP5 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 4:129,810,650...129,838,628
Ensembl chr 4:129,810,645...129,838,608
|
|
G |
Armc12 |
armadillo repeat containing 12 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to ARMC12 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr20:6,587,859...6,598,355
Ensembl chr20:6,587,859...6,598,352
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
multiple interactions increases expression increases localization |
ISO EXP |
[AHR gene mutant form binds to ARNT protein] which results in decreased susceptibility to Methylcholanthrene; Methylcholanthrene promotes the reaction [[AHR protein binds to ARNT protein] which binds to CYP1A1 enhancer]; Methylcholanthrene promotes the reaction [[AHR protein binds to ARNT protein] which results in increased expression of CYP1A1 mRNA]; Methylcholanthrene promotes the reaction [ARNT protein binds to CCNG2 promoter]; Methylcholanthrene promotes the reaction [ARNT protein binds to CYP1A1 promoter]; Methylcholanthrene promotes the reaction [ARNT protein binds to CYP1B1 promoter]; Methylcholanthrene promotes the reaction [ARNT protein binds to ESR1 promoter]; Methylcholanthrene promotes the reaction [ARNT protein binds to FOXN4 promoter]; Methylcholanthrene promotes the reaction [ARNT protein binds to SORL1 promoter] Methylcholanthrene results in increased expression of ARNT mRNA Methylcholanthrene results in increased localization of ARNT protein Cycloheximide promotes the reaction [Methylcholanthrene promotes the reaction [ARNT protein binds to CYP1A1 enhancer]]; Methylcholanthrene promotes the reaction [ARNT protein binds to CYP1A1 enhancer] |
CTD |
PMID:11768231 PMID:19951702 PMID:20348232 PMID:20570689 PMID:21756928 PMID:23273579 PMID:24486526 More...
|
|
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
|
|
G |
Arrb1 |
arrestin, beta 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ARRB1 mRNA |
CTD |
PMID:29554273 |
|
NCBI chr 1:153,837,964...153,912,111
Ensembl chr 1:153,838,078...153,904,061
|
|
G |
Art3 |
ADP-ribosyltransferase 3 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of ART3 mRNA |
CTD |
PMID:23519560 |
|
NCBI chr14:15,637,230...15,719,442
Ensembl chr14:15,637,237...15,665,407
|
|
G |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in increased expression of ASCL1 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 7:21,903,136...21,906,003
Ensembl chr 7:21,903,126...21,905,993
|
|
G |
Asf1b |
anti-silencing function 1B histone chaperone |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ASF1B mRNA |
CTD |
PMID:20713471 |
|
NCBI chr19:24,181,024...24,195,604
Ensembl chr19:24,181,028...24,195,549
|
|
G |
Asic1 |
acid sensing ion channel subunit 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ASIC1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 7:130,798,317...130,828,535
Ensembl chr 7:130,799,917...130,828,541
|
|
G |
Aspm |
assembly factor for spindle microtubules |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ASPM mRNA |
CTD |
PMID:20713471 |
|
NCBI chr13:51,074,849...51,123,755
Ensembl chr13:51,074,849...51,123,755
|
|
G |
Aspn |
asporin |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of ASPN mRNA |
CTD |
PMID:20713471 |
|
NCBI chr17:15,079,910...15,104,369
Ensembl chr17:15,080,639...15,104,041
|
|
G |
Atad2 |
ATPase family, AAA domain containing 2 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ATAD2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 7:89,634,123...89,676,738
Ensembl chr 7:89,634,123...89,676,738
|
|
G |
Atox1 |
antioxidant 1 copper chaperone |
increases expression |
EXP |
Methylcholanthrene results in increased expression of ATOX1 mRNA |
CTD |
PMID:23273579 |
|
NCBI chr10:39,564,855...39,579,892
Ensembl chr10:39,564,857...39,579,950
|
|
G |
Atp6v1c2 |
ATPase H+ transporting V1 subunit C2 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of ATP6V1C2 mRNA |
CTD |
PMID:23519560 |
|
NCBI chr 6:40,080,545...40,144,199
Ensembl chr 6:40,080,547...40,120,028
|
|
G |
Aurka |
aurora kinase A |
increases expression |
ISO |
Methylcholanthrene results in increased expression of AURKA mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
|
|
G |
Aurkb |
aurora kinase B |
increases expression |
ISO |
Methylcholanthrene results in increased expression of AURKB mRNA |
CTD |
PMID:20713471 |
|
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
|
|
G |
Bad |
BCL2-associated agonist of cell death |
increases expression |
EXP |
Methylcholanthrene results in increased expression of BAD mRNA |
CTD |
PMID:23273579 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Baiap2 |
BAR/IMD domain containing adaptor protein 2 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of BAIAP2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr10:105,223,065...105,290,130
Ensembl chr10:105,223,090...105,290,134
|
|
G |
Bambi |
BMP and activin membrane-bound inhibitor |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to BAMBI promoter] |
CTD |
PMID:20348232 |
|
NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression increases methylation multiple interactions |
EXP |
Methylcholanthrene results in increased expression of BAX mRNA Methylcholanthrene results in increased methylation of BAX promoter alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to BAX promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of BAX mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of BAX promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to BAX promoter] |
CTD |
PMID:23273579 PMID:29094188 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbx |
BBX high mobility group box domain containing |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to BBX promoter] |
CTD |
PMID:20348232 |
|
NCBI chr11:50,381,249...50,628,934
Ensembl chr11:50,381,247...50,623,251
|
|
G |
Bcas3 |
BCAS3, microtubule associated cell migration factor |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of BCAS3 mRNA |
CTD |
PMID:22100608 |
|
NCBI chr10:70,213,710...70,673,080
Ensembl chr10:70,214,098...70,673,080
|
|
G |
Bcl10 |
BCL10, immune signaling adaptor |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in increased expression of BCL10 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 2:234,840,880...234,850,520
Ensembl chr 2:234,840,858...234,850,523
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
increases expression decreases expression |
EXP ISO |
Methylcholanthrene results in increased expression of BCL2 mRNA Methylcholanthrene results in decreased expression of BCL2 mRNA |
CTD |
PMID:23273579 PMID:35487396 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl6 |
BCL6, transcription repressor |
increases expression multiple interactions |
ISO |
Methylcholanthrene results in increased expression of BCL6 mRNA Methylcholanthrene promotes the reaction [AHR protein binds to BCL6 promoter] |
CTD |
PMID:20348232 PMID:20713471 PMID:25926378 |
|
NCBI chr11:76,854,090...76,877,389
Ensembl chr11:76,854,090...76,877,389
|
|
G |
Bdh2 |
3-hydroxybutyrate dehydrogenase 2 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of BDH2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 2:223,702,410...223,723,076
Ensembl chr 2:223,702,412...223,723,072
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of BIRC3 mRNA |
CTD |
PMID:29554273 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of BIRC5 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Bmf |
Bcl2 modifying factor |
increases expression |
ISO |
Methylcholanthrene results in increased expression of BMF mRNA |
CTD |
PMID:29554273 |
|
NCBI chr 3:105,499,534...105,520,159
Ensembl chr 3:105,499,538...105,520,145
|
|
G |
Bmp15 |
bone morphogenetic protein 15 |
multiple interactions |
EXP |
[Methylcholanthrene co-treated with alpha-naphthoflavone] results in increased expression of BMP15 mRNA |
CTD |
PMID:29094188 |
|
NCBI chr X:16,169,123...16,174,187
Ensembl chr X:16,169,123...16,174,187
|
|
G |
Bmp4 |
bone morphogenetic protein 4 |
decreases expression |
EXP |
Methylcholanthrene results in decreased expression of BMP4 mRNA |
CTD |
PMID:29094188 |
|
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
|
|
G |
Bpgm |
bisphosphoglycerate mutase |
increases expression |
ISO |
Methylcholanthrene results in increased expression of BPGM mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 4:63,139,730...63,168,581
Ensembl chr 4:63,140,018...63,168,581
|
|
G |
Bpifa2 |
BPI fold containing family A, member 2 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to BPIFA2 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 3:142,493,379...142,501,343
Ensembl chr 3:142,493,379...142,501,337
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
multiple interactions increases expression |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to BRCA1 protein] Methylcholanthrene results in increased expression of BRCA1 mRNA |
CTD |
PMID:18259752 PMID:20713471 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Bri3bp |
Bri3 binding protein |
increases expression |
ISO |
Methylcholanthrene results in increased expression of BRI3BP mRNA |
CTD |
PMID:25926378 |
|
NCBI chr12:31,176,742...31,188,563
Ensembl chr12:31,173,971...31,188,572
|
|
G |
Brip1 |
BRCA1 interacting helicase 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of BRIP1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr10:70,907,266...71,031,502
Ensembl chr10:70,907,371...71,030,324
|
|
G |
Bst1 |
bone marrow stromal cell antigen 1 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of BST1 mRNA |
CTD |
PMID:23519560 |
|
NCBI chr14:67,253,706...67,270,203
Ensembl chr14:67,252,998...67,270,180
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of BTG2 mRNA |
CTD |
PMID:22100608 |
|
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
|
|
G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
increases expression |
ISO |
Methylcholanthrene results in increased expression of BUB1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
|
|
G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
increases expression |
ISO |
Methylcholanthrene results in increased expression of BUB1B mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
|
|
G |
C14h4orf19 |
similar to human chromosome 4 open reading frame 19 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to C4ORF19 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr14:44,387,386...44,478,344
Ensembl chr14:44,387,393...44,478,041
|
|
G |
C14h4orf36 |
similar to human chromosome 4 open reading frame 36 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to C4ORF36 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr14:6,058,581...6,065,848
Ensembl chr14:6,058,581...6,065,847
|
|
G |
C19h16orf74 |
similar to human chromosome 16 open reading frame 74 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to C16ORF74 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr19:48,660,288...48,686,287
Ensembl chr19:48,660,288...48,686,349
|
|
G |
C1qbp |
complement C1q binding protein |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of C1QBP mRNA |
CTD |
PMID:25926378 |
|
NCBI chr10:55,699,954...55,704,605
Ensembl chr10:55,699,954...55,704,649
|
|
G |
C3 |
complement C3 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of C3 mRNA |
CTD |
PMID:16257430 PMID:29554273 |
|
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
C4a |
complement C4A |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of C4A mRNA |
CTD |
PMID:23519560 |
|
NCBI chr20:4,005,731...4,020,083
Ensembl chr20:4,005,731...4,020,080
|
|
G |
C4b |
complement C4B (Chido blood group) |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of C4B mRNA |
CTD |
PMID:23519560 |
|
NCBI chr20:4,197,371...4,211,684
Ensembl chr20:4,197,366...4,211,681
|
|
G |
C6 |
complement C6 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of C6 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 2:53,846,028...53,921,279
Ensembl chr 2:53,851,985...53,921,275
|
|
G |
Cacna1b |
calcium voltage-gated channel subunit alpha1 B |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to CACNA1B promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 3:7,380,892...7,546,104
Ensembl chr 3:7,380,922...7,546,091
|
|
G |
Cacna1g |
calcium voltage-gated channel subunit alpha1 G |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CACNA1G mRNA |
CTD |
PMID:23519560 |
|
NCBI chr10:79,354,998...79,422,960
Ensembl chr10:79,355,008...79,422,752
|
|
G |
Cadm1 |
cell adhesion molecule 1 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with Methylcholanthrene] results in decreased expression of CADM1 protein; [Diethylnitrosamine co-treated with Methylcholanthrene] results in increased methylation of CADM1 gene |
CTD |
PMID:21163286 |
|
NCBI chr 8:47,847,836...48,178,703
Ensembl chr 8:47,847,325...48,182,833
|
|
G |
Calb2 |
calbindin 2 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to CALB2 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr19:38,114,435...38,141,438
Ensembl chr19:38,114,424...38,141,438
|
|
G |
Calcrl |
calcitonin receptor like receptor |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of CALCRL mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 3:69,428,348...69,525,910
Ensembl chr 3:69,430,120...69,525,910
|
|
G |
Calm1 |
calmodulin 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CALM1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 6:119,487,691...119,495,759
Ensembl chr 6:119,487,621...119,498,227
|
|
G |
Calr |
calreticulin |
increases expression multiple interactions |
EXP |
Methylcholanthrene results in increased expression of CALR mRNA alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of CALR mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
|
|
G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CAMK2B mRNA |
CTD |
PMID:23519560 |
|
NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994
|
|
G |
Capg |
capping actin protein, gelsolin like |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CAPG mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 4:104,594,743...104,611,856
Ensembl chr 4:104,594,753...104,611,856
|
|
G |
Caps |
calcyphosine |
increases expression multiple interactions |
ISO |
Methylcholanthrene results in increased expression of TNFRSF23 mRNA [Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of TNFRSF23 mRNA |
CTD |
PMID:20713471 PMID:25926378 |
|
NCBI chr 9:1,544,597...1,545,631
Ensembl chr 9:1,544,719...1,545,647
|
|
G |
Car12 |
carbonic anhydrase 12 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to CA12 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 8:67,274,739...67,330,428
Ensembl chr 8:67,274,359...67,330,440
|
|
G |
Car8 |
carbonic anhydrase 8 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to CA8 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 5:21,302,940...21,402,395
Ensembl chr 5:21,305,383...21,402,374
|
|
G |
Cask |
calcium/calmodulin dependent serine protein kinase |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of CASK mRNA |
CTD |
PMID:20713471 |
|
NCBI chr X:8,899,500...9,243,014
Ensembl chr X:8,899,833...9,238,694
|
|
G |
Casp3 |
caspase 3 |
increases expression multiple interactions |
ISO EXP |
Methylcholanthrene results in increased expression of CASP3 mRNA Methylcholanthrene inhibits the reaction [3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole results in increased cleavage of and results in increased activity of CASP3 protein] |
CTD |
PMID:11323195 PMID:11999409 PMID:20713471 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
increases expression increases methylation multiple interactions |
EXP |
Methylcholanthrene results in increased expression of CASP9 mRNA Methylcholanthrene results in increased methylation of CASP9 promoter [alpha-naphthoflavone co-treated with Methylcholanthrene] results in decreased acetylation of CASP9 promoter; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to CASP9 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of CASP9 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of CASP9 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to CASP9 promoter] |
CTD |
PMID:23273579 PMID:29094188 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cast |
calpastatin |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to CAST promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:3,973,112...4,082,659
|
|
G |
Ccdc57 |
coiled-coil domain containing 57 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to CCDC57 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr10:106,092,784...106,196,405
Ensembl chr10:106,092,947...106,196,077
|
|
G |
Ccdc6 |
coiled-coil domain containing 6 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to CCDC6 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr20:18,432,177...18,528,186
Ensembl chr20:18,433,695...18,528,658
|
|
G |
Ccl17 |
C-C motif chemokine ligand 17 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of CCL17 mRNA |
CTD |
PMID:29554273 |
|
NCBI chr19:10,202,128...10,203,903
Ensembl chr19:10,202,128...10,203,819
|
|
G |
Ccl19 |
C-C motif chemokine ligand 19 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of CCL19 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 5:56,963,364...56,965,308
Ensembl chr 5:56,963,364...56,965,308
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CCL2 mRNA |
CTD |
PMID:20713471 PMID:23397585 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of CCL5 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CCL7 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
|
|
G |
Ccn1 |
cellular communication network factor 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CCN1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
|
|
G |
Ccn3 |
cellular communication network factor 3 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CCN3 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 7:86,094,000...86,101,022
Ensembl chr 7:86,094,000...86,101,019
|
|
G |
Ccn4 |
cellular communication network factor 4 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of CCN4 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 7:98,645,238...98,677,253
Ensembl chr 7:98,645,182...98,677,248
|
|
G |
Ccn5 |
cellular communication network factor 5 |
increases expression multiple interactions |
ISO |
Methylcholanthrene results in increased expression of CCN5 mRNA Methylcholanthrene promotes the reaction [AHR protein binds to CCN5 promoter] |
CTD |
PMID:20348232 PMID:20713471 |
|
NCBI chr 3:152,491,247...152,502,639
Ensembl chr 3:152,491,220...152,502,636
|
|
G |
Ccna2 |
cyclin A2 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CCNA2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
increases expression |
ISO EXP |
Methylcholanthrene results in increased expression of CCNB1 mRNA |
CTD |
PMID:20713471 PMID:26372666 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnb2 |
cyclin B2 |
increases expression multiple interactions |
ISO EXP |
Methylcholanthrene results in increased expression of CCNB2 mRNA Methylcholanthrene inhibits the reaction [Estradiol results in increased expression of CCNB2 mRNA] |
CTD |
PMID:20713471 PMID:26372666 |
|
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
|
|
G |
Ccnd1 |
cyclin D1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CCND1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccne1 |
cyclin E1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CCNE1 mRNA |
CTD |
PMID:29554273 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Ccne2 |
cyclin E2 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CCNE2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
|
|
G |
Ccng2 |
cyclin G2 |
multiple interactions increases expression |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to CCNG2 promoter]; Methylcholanthrene promotes the reaction [ARNT protein binds to CCNG2 promoter]; Methylcholanthrene promotes the reaction [Methylcholanthrene results in increased expression of CCNG2 mRNA] |
CTD |
PMID:20348232 |
|
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
|
|
G |
Cd300e |
Cd300e molecule |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CD300E mRNA |
CTD |
PMID:25926378 |
|
NCBI chr10:100,289,729...100,309,996
Ensembl chr10:100,291,437...100,299,311
|
|
G |
Cd300lb |
CD300 molecule-like family member b |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CD300LB mRNA |
CTD |
PMID:20713471 |
|
NCBI chr10:99,964,801...99,974,790
Ensembl chr10:99,964,801...99,974,790
|
|
G |
Cd3d |
CD3 delta subunit of T-cell receptor complex |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of CD3D mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 8:45,287,803...45,293,342
Ensembl chr 8:45,288,749...45,301,809
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
multiple interactions increases expression |
ISO |
[Butylated Hydroxytoluene co-treated with Methylcholanthrene] results in increased expression of CD44 mRNA alternative form Methylcholanthrene results in increased expression of CD44 mRNA |
CTD |
PMID:15390079 PMID:20713471 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cd48 |
Cd48 molecule |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CD48 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr13:84,184,884...84,209,144
Ensembl chr13:84,185,532...84,209,142
|
|
G |
Cd5 |
Cd5 molecule |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CD5 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 1:207,365,337...207,386,313
Ensembl chr 1:207,365,337...207,386,313
|
|
G |
Cd55 |
CD55 molecule (Cromer blood group) |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to CD55 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr13:41,857,242...41,885,966
Ensembl chr13:41,857,395...41,885,831
|
|
G |
Cd59b |
CD59b molecule |
increases mutagenesis |
ISO |
Methylcholanthrene results in increased mutagenesis of CD59 protein |
CTD |
PMID:17045307 |
|
NCBI chr 3:90,459,085...90,477,571
Ensembl chr 3:90,459,162...90,478,847
|
|
G |
Cd9 |
CD9 molecule |
multiple interactions decreases expression |
EXP |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased expression of CD9 mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222
|
|
G |
Cd96 |
CD96 molecule |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of CD96 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr11:54,702,290...54,776,618
Ensembl chr11:54,702,290...54,776,621
|
|
G |
Cda |
cytidine deaminase |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CDA mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 5:150,556,615...150,583,231
Ensembl chr 5:150,556,615...150,583,231
|
|
G |
Cdc20 |
cell division cycle 20 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CDC20 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
|
|
G |
Cdc25c |
cell division cycle 25C |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CDC25C mRNA |
CTD |
PMID:20713471 |
|
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdc45 |
cell division cycle 45 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CDC45 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr11:82,185,427...82,210,630
Ensembl chr11:82,185,473...82,210,619
|
|
G |
Cdc6 |
cell division cycle 6 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CDC6 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011
|
|
G |
Cdca2 |
cell division cycle associated 2 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CDCA2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr15:41,895,946...41,942,226
Ensembl chr15:41,895,901...41,941,611
|
|
G |
Cdca3 |
cell division cycle associated 3 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CDCA3 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799
|
|
G |
Cdca5 |
cell division cycle associated 5 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CDCA5 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 1:203,378,550...203,392,027
Ensembl chr 1:203,378,577...203,392,023
|
|
G |
Cdca8 |
cell division cycle associated 8 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CDCA8 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 5:137,176,414...137,198,686
Ensembl chr 5:137,176,417...137,198,629
|
|
G |
Cdh1 |
cadherin 1 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of CDH1 protein |
CTD |
PMID:16619036 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh13 |
cadherin 13 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of CDH13 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr19:46,349,562...47,387,462
Ensembl chr19:46,349,430...47,387,459
|
|
G |
Cdh2 |
cadherin 2 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with Methylcholanthrene] affects the expression of CDH2 protein; [Diethylnitrosamine co-treated with Methylcholanthrene] results in increased expression of CDH2 protein; [Diethylnitrosamine co-treated with Methylcholanthrene] results in increased methylation of CDH2 gene |
CTD |
PMID:21163286 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Cdh5 |
cadherin 5 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of CDH5 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr19:815,415...854,478
Ensembl chr19:815,411...854,368
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression multiple interactions decreases methylation increases expression increases acetylation |
ISO EXP |
Methylcholanthrene results in decreased expression of CDK2 protein alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to CDK2 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased methylation of CDK2 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased acetylation of CDK2 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of CDK2 mRNA]; Methylcholanthrene promotes the reaction [AHR protein binds to CDK2 promoter] |
CTD |
PMID:18022818 PMID:29094188 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression increases response to substance multiple interactions |
ISO |
Methylcholanthrene results in increased expression of CDKN1A mRNA Methylcholanthrene results in increased expression of CDKN1A protein CDKN1A protein results in increased susceptibility to Methylcholanthrene Acetylcysteine inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1A protein]; resveratrol inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1A protein] SB 203580 inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1A mRNA] |
CTD |
PMID:15882963 PMID:18022818 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions increases response to substance increases expression |
ISO |
Acetylcysteine inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1B protein]; resveratrol inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1B protein] CDKN1B protein results in increased susceptibility to Methylcholanthrene |
CTD |
PMID:18022818 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn2aipnl |
CDKN2A interacting protein N-terminal like |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CDKN2AIPNL mRNA |
CTD |
PMID:20713471 |
|
NCBI chr10:36,231,134...36,240,569
Ensembl chr10:36,231,087...36,240,564
|
|
G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CDKN3 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945
|
|
G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CDT1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659
|
|
G |
Ceacam19 |
CEA cell adhesion molecule 19 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CEACAM19 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 1:79,542,107...79,550,927
Ensembl chr 1:79,542,107...79,550,927
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CEBPA mRNA |
CTD |
PMID:23519560 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
multiple interactions |
ISO |
[Capsaicin results in increased activity of CEBPB protein] inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; [Capsaicin results in increased activity of CEBPB protein] inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 protein] |
CTD |
PMID:21250977 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cenpa |
centromere protein A |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CENPA mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675
|
|
G |
Cenpe |
centromere protein E |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CENPE mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 2:223,637,035...223,695,692
Ensembl chr 2:223,636,998...223,695,669
|
|
G |
Cenpf |
centromere protein F |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CENPF mRNA |
CTD |
PMID:20713471 |
|
NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
|
|
G |
Cenph |
centromere protein H |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CENPH mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 2:31,896,675...31,910,179
Ensembl chr 2:31,894,667...31,910,154
|
|
G |
Cenpi |
centromere protein I |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CENPI mRNA |
CTD |
PMID:20713471 |
|
NCBI chr X:97,515,919...97,567,671
Ensembl chr X:97,515,972...97,567,657
|
|
G |
Cenpk |
centromere protein K |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CENPK mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 2:35,360,390...35,421,372
Ensembl chr 2:35,360,132...35,385,706
|
|
G |
Cenpl |
centromere protein L |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to CENPL promoter] |
CTD |
PMID:20348232 |
|
NCBI chr13:73,337,235...73,352,115
Ensembl chr13:73,337,257...73,352,114
|
|
G |
Cenpu |
centromere protein U |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CENPU mRNA |
CTD |
PMID:20713471 |
|
NCBI chr16:45,715,821...45,739,038
Ensembl chr16:45,714,294...45,738,823
|
|
G |
Cep55 |
centrosomal protein 55 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CEP55 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 1:235,832,823...235,848,401
Ensembl chr 1:235,832,878...235,848,394
|
|
G |
Cep70 |
centrosomal protein 70 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to CEP70 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 8:99,810,270...99,863,279
Ensembl chr 8:99,810,367...99,862,855
|
|
G |
Ces1d |
carboxylesterase 1D |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of CES1 protein |
CTD |
PMID:10640517 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Ces2h |
carboxylesterase 2H |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of CES2 protein |
CTD |
PMID:10640517 |
|
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
|
|
G |
Ces3a |
carboxylesterase 3a |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CES3 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr19:32,992,386...33,000,562
|
|
G |
Cfap61 |
cilia and flagella associated protein 61 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to CFAP61 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 3:133,354,400...133,633,310
Ensembl chr 3:133,354,197...133,633,320
|
|
G |
Chd1l |
chromodomain helicase DNA binding protein 1-like |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CHD1L mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 2:185,138,526...185,217,498
Ensembl chr 2:185,139,308...185,217,595
|
|
G |
Chd8 |
chromodomain helicase DNA binding protein 8 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CHD8 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr15:24,905,789...24,965,461
Ensembl chr15:24,905,789...24,951,285
|
|
G |
Chfr |
checkpoint with forkhead and ring finger domains |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of CHFR mRNA |
CTD |
PMID:25926378 |
|
NCBI chr12:46,504,497...46,538,104
Ensembl chr12:46,504,497...46,538,014
|
|
G |
Chi3l1 |
chitinase 3 like 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CHI3L1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr13:45,641,802...45,649,787
Ensembl chr13:45,641,802...45,649,787
|
|
G |
Chic1 |
cysteine-rich hydrophobic domain 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CHIC1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr X:68,362,014...68,406,155
Ensembl chr X:68,361,969...68,437,887
|
|
G |
Chic2 |
cysteine-rich hydrophobic domain 2 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of CHIC2 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr14:33,157,669...33,192,015
Ensembl chr14:33,157,537...33,191,895
|
|
G |
Chka |
choline kinase alpha |
increases expression |
EXP |
Methylcholanthrene results in increased expression of CHKA mRNA |
CTD |
PMID:7852267 |
|
NCBI chr 1:201,076,804...201,125,517
Ensembl chr 1:201,076,860...201,125,516
|
|
G |
Chpt1 |
choline phosphotransferase 1 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to CHPT1 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 7:22,866,455...22,915,111
Ensembl chr 7:22,863,027...22,915,103
|
|
G |
Chrdl2 |
chordin-like 2 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to CHRDL2 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 1:154,343,201...154,370,651
Ensembl chr 1:154,343,201...154,370,640
|
|
G |
Chrnb1 |
cholinergic receptor nicotinic beta 1 subunit |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CHRNB1 mRNA |
CTD |
PMID:23519560 |
|
NCBI chr10:54,501,096...54,516,418
Ensembl chr10:54,501,093...54,516,345
|
|
G |
Cilk1 |
ciliogenesis associated kinase 1 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to CILK1 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 8:78,984,075...79,042,695
Ensembl chr 8:78,984,258...79,042,691
|
|
G |
Cisd1 |
CDGSH iron sulfur domain 1 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to CISD1 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr20:17,255,302...17,268,688
Ensembl chr20:17,255,151...17,284,924
|
|
G |
Cish |
cytokine inducible SH2-containing protein |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of CISH mRNA |
CTD |
PMID:22978700 |
|
NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250
|
|
G |
Ckap2 |
cytoskeleton associated protein 2 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CKAP2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr16:69,839,668...69,864,852
Ensembl chr16:69,839,630...69,864,913
|
|
G |
Ckap2l |
cytoskeleton associated protein 2-like |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CKAP2L mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 3:116,497,186...116,524,302
Ensembl chr 3:116,498,022...116,524,366
|
|
G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CKS2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr17:13,570,611...13,575,770
|
|
G |
Cldn17 |
claudin 17 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to CLDN17 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr11:27,827,454...27,828,630
Ensembl chr11:27,827,454...27,828,630
|
|
G |
Clk3 |
CDC-like kinase 3 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to CLK3 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 8:58,152,155...58,167,196
Ensembl chr 8:58,152,155...58,168,181
|
|
G |
Clpsl2 |
colipase-like 2 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to CLPSL2 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr20:6,608,128...6,610,951
Ensembl chr20:6,608,128...6,610,951
|
|
G |
Clspn |
claspin |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CLSPN mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 5:138,850,119...138,885,037
Ensembl chr 5:138,850,128...138,885,034
|
|
G |
Cmip |
c-Maf-inducing protein |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of CMIP mRNA |
CTD |
PMID:25926378 |
|
NCBI chr19:45,304,597...45,510,653
Ensembl chr19:45,304,031...45,508,709
|
|
G |
Cnst |
consortin, connexin sorting protein |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CNST mRNA |
CTD |
PMID:23397585 |
|
NCBI chr13:91,296,740...91,373,531
Ensembl chr13:91,296,142...91,373,531
|
|
G |
Cntn1 |
contactin 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CNTN1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 7:123,263,146...123,560,896
Ensembl chr 7:123,372,792...123,558,541
|
|
G |
Col11a1 |
collagen type XI alpha 1 chain |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of COL11A1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 2:201,820,715...202,013,853
Ensembl chr 2:201,820,715...202,013,853
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of COL3A1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Col5a1 |
collagen type V alpha 1 chain |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of COL5A1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 3:11,208,429...11,356,715
Ensembl chr 3:11,208,512...11,354,588
|
|
G |
Col5a2 |
collagen type V alpha 2 chain |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of COL5A2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 9:47,448,741...47,598,134
Ensembl chr 9:47,448,736...47,598,154
|
|
G |
Col8a1 |
collagen type VIII alpha 1 chain |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of COL8A1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr11:42,776,851...42,906,432
Ensembl chr11:42,777,628...42,906,424
|
|
G |
Cotl1 |
coactosin-like F-actin binding protein 1 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of COTL1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr19:47,871,689...47,906,010
Ensembl chr19:47,871,694...47,911,689
|
|
G |
Cox4i1 |
cytochrome c oxidase subunit 4i1 |
multiple interactions increases expression |
ISO EXP |
Methylcholanthrene promotes the reaction [AHR protein binds to COX4I1 promoter] Methylcholanthrene results in increased expression of COX4I1 mRNA |
CTD |
PMID:20348232 PMID:23273579 |
|
NCBI chr19:48,721,680...48,727,920
Ensembl chr19:48,721,199...48,727,921
|
|
G |
Cpox |
coproporphyrinogen oxidase |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CPOX mRNA |
CTD |
PMID:20713471 |
|
NCBI chr11:41,936,585...41,946,568
Ensembl chr11:41,936,591...41,946,746
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
increases expression |
EXP |
Methylcholanthrene results in increased expression of CPT1A protein |
CTD |
PMID:25786523 |
|
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
increases expression |
EXP |
Methylcholanthrene results in increased expression of CREB1 mRNA |
CTD |
PMID:23273579 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Crem |
cAMP responsive element modulator |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of CREM mRNA |
CTD |
PMID:35487396 |
|
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
|
|
G |
Crkl |
CRK like proto-oncogene, adaptor protein |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to CRKL promoter] |
CTD |
PMID:20348232 |
|
NCBI chr11:83,528,788...83,563,214
Ensembl chr11:83,526,530...83,563,238
|
|
G |
Cryz |
crystallin zeta |
multiple interactions increases expression increases activity |
ISO |
AHR protein promotes the reaction [Methylcholanthrene results in increased activity of CRYZ protein]; Copper inhibits the reaction [Methylcholanthrene results in increased activity of CRYZ protein]; Copper inhibits the reaction [Methylcholanthrene results in increased expression of CRYZ mRNA]; Lead inhibits the reaction [Methylcholanthrene results in increased expression of CRYZ mRNA]; Lead promotes the reaction [Methylcholanthrene results in increased activity of CRYZ protein]; Mercury promotes the reaction [Methylcholanthrene results in increased activity of CRYZ protein]; Mercury promotes the reaction [Methylcholanthrene results in increased expression of CRYZ mRNA] |
CTD |
PMID:15297030 |
|
NCBI chr 2:243,552,037...243,580,369
Ensembl chr 2:243,552,119...243,579,758
|
|
G |
Csmd3 |
CUB and Sushi multiple domains 3 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of CSMD3 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 7:78,747,322...80,066,466
Ensembl chr 7:78,748,480...80,066,369
|
|
G |
Csn2 |
casein beta |
multiple interactions |
EXP |
Methylcholanthrene inhibits the reaction [8-prenylnaringenin results in increased expression of CSN2 mRNA] |
CTD |
PMID:26372666 |
|
NCBI chr14:20,322,581...20,329,818
Ensembl chr14:20,322,581...20,329,817
|
|
G |
Csrp2 |
cysteine and glycine-rich protein 2 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CSRP2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 7:46,349,109...46,367,743
Ensembl chr 7:46,348,686...46,367,745
|
|
G |
Ctnna1 |
catenin alpha 1 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to CTNNA1 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr18:26,728,246...26,860,911
Ensembl chr18:26,728,485...26,860,910
|
|
G |
Ctnnb1 |
catenin beta 1 |
affects response to substance increases response to substance multiple interactions |
ISO |
CTNNB1 protein affects the susceptibility to Methylcholanthrene CTNNB1 protein results in increased susceptibility to Methylcholanthrene CTNNB1 gene mutant form affects the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; CTNNB1 gene mutant form affects the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA]; CTNNB1 protein affects the reaction [[Methylcholanthrene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA] |
CTD |
PMID:21498875 PMID:25174530 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Ctsd |
cathepsin D |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CTSD mRNA |
CTD |
PMID:16257430 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Cuedc1 |
CUE domain containing 1 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to CUEDC1 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr10:72,892,637...72,986,546
Ensembl chr10:72,892,637...72,986,542
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CX3CL1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CXCL10 mRNA |
CTD |
PMID:23519560 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CXCL12 mRNA |
CTD |
PMID:23519560 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cxcl6 |
C-X-C motif chemokine ligand 6 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CXCL5 mRNA |
CTD |
PMID:23519560 |
|
NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093
|
|
G |
Cyb5b |
cytochrome b5 type B |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to CYB5B promoter] |
CTD |
PMID:20348232 |
|
NCBI chr19:35,062,871...35,096,741
Ensembl chr19:35,062,813...35,098,249
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of CYP11A1 mRNA |
CTD |
PMID:35487396 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
affects expression |
ISO |
Methylcholanthrene affects the expression of CYP17A1 mRNA |
CTD |
PMID:35487396 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases expression decreases response to substance increases acetylation increases methylation increases activity increases metabolic processing decreases activity |
ISO EXP |
[Celsior co-treated with Methylcholanthrene] results in increased expression of CYP1A1 mRNA; [Dexamethasone co-treated with Mifepristone] promotes the reaction [Methylcholanthrene results in increased activity of CYP1A1 protein]; [Methylcholanthrene co-treated with Oxygen deficiency] results in increased expression of CYP1A1 mRNA; [Methylcholanthrene co-treated with Rifampin co-treated with Phenobarbital] results in increased expression of CYP1A1 mRNA; [Methylcholanthrene results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA; [NR3C1 protein co-treated with Dexamethasone] inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; [pirinixic acid co-treated with Methylcholanthrene] results in increased activity of CYP1A1 protein; [pirinixic acid co-treated with Methylcholanthrene] results in increased expression of CYP1A1 mRNA; AHR gene mutant form inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; AHR protein affects the susceptibility to [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; AHR protein promotes the reaction [Methylcholanthrene results in increased activity of CYP1A1 protein]; AHR protein promotes the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; AHR protein promotes the reaction [Methylcholanthrene results in increased expression of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; Arsenic Trioxide inhibits the reaction [Methylcholanthrene results in increased expression of and results in increased activity of CYP1A1 protein]; Arsenic Trioxide inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; Dexamethasone inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A1 protein]; Dexamethasone inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; Dexamethasone inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 protein]; Dexamethasone promotes the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; Glyburide inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; Methylcholanthrene promotes the reaction [[AHR protein binds to ARNT protein] which binds to CYP1A1 enhancer]; Methylcholanthrene promotes the reaction [[AHR protein binds to ARNT protein] which results in increased expression of CYP1A1 mRNA]; Methylcholanthrene promotes the reaction [AHR protein binds to CYP1A1 promoter]; Methylcholanthrene promotes the reaction [ARNT protein binds to CYP1A1 promoter]; Methylcholanthrene promotes the reaction [ESR1 protein binds to CYP1A1 promoter]; Methylcholanthrene promotes the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; Methylcholanthrene promotes the reaction [Nicardipine results in increased activity of and results in increased expression of CYP1A1 protein]; Methylcholanthrene promotes the reaction [Nicardipine results in increased expression of CYP1A1 mRNA]; Methylcholanthrene promotes the reaction [pirinixic acid results in increased activity of CYP1A1 protein]; Methylcholanthrene promotes the reaction [pirinixic acid results in increased expression of CYP1A1 mRNA]; Methylcholanthrene results in increased expression of and results in increased activity of CYP1A1 protein; Nicardipine promotes the reaction [Methylcholanthrene results in increased activity of and results in increased expression of CYP1A1 protein]; Nicardipine promotes the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; Oxygen deficiency affects the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; SPTLC1 protein inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; SPTLC1 protein mutant form inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; tyrphostin AG 1024 inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; tyrphostin AG 1024 inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 protein] 3-methylcholanthrene increases expression of mRNA, protein in rat heart CYP1A1 gene mutant form results in decreased susceptibility to Methylcholanthrene Methylcholanthrene results in increased acetylation of CYP1A1 promoter Methylcholanthrene results in increased methylation of CYP1A1 promoter Methylcholanthrene results in increased expression of CYP1A1 mRNA; Methylcholanthrene results in increased expression of CYP1A1 protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Methylcholanthrene results in increased activity of and results in increased expression of CYP1A1 protein]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; [Capsaicin results in increased activity of CEBPB protein] inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; [Capsaicin results in increased activity of CEBPB protein] inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 protein]; [Methylcholanthrene binds to and affects the localization of AHR protein] promotes the reaction [[AHR protein binds to CYP1A1 enhancer] which results in increased expression of CYP1A1 mRNA]; [Methylcholanthrene binds to and affects the localization of AHR protein] which results in increased expression of CYP1A1 mRNA; [Methylcholanthrene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA; AHR affects the reaction [Methylcholanthrene results in increased activity of and results in increased expression of CYP1A1 protein]; AHR affects the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; AHR protein affects the reaction [Methylcholanthrene affects the expression of CYP1A1 mRNA]; AHR protein promotes the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; AHR protein promotes the reaction [Methylcholanthrene results in increased expression of CYP1A1 protein]; Arsenic inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A1 protein]; Arsenic promotes the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; Arsenic promotes the reaction [Methylcholanthrene results in increased expression of CYP1A1 protein]; Cadmium inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A1 protein]; Cadmium promotes the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; Cadmium promotes the reaction [Methylcholanthrene results in increased expression of CYP1A1 protein]; Capsaicin inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; Capsaicin inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 protein]; Chromium inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A1 protein]; Chromium promotes the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; Chromium promotes the reaction [Methylcholanthrene results in increased expression of CYP1A1 protein]; Copper inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A1 protein]; Copper inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; Copper inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 protein]; CTNNB1 gene mutant form affects the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; CTNNB1 protein affects the reaction [[Methylcholanthrene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]; Cycloheximide promotes the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to CYP1A1 enhancer]]; Cycloheximide promotes the reaction [Methylcholanthrene promotes the reaction [ARNT protein binds to CYP1A1 enhancer]]; Cycloheximide promotes the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; CYP1A1 gene mutant form promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA]; CYP1A2 gene mutant form promotes the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; Lead inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A1 protein]; Lead inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; Mercury inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A1 protein]; Mercury promotes the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; Mercury promotes the reaction [Methylcholanthrene results in increased expression of CYP1A1 protein]; Methylcholanthrene promotes the reaction [AHR protein binds to CYP1A1 enhancer]; Methylcholanthrene promotes the reaction [AHR protein binds to CYP1A1 promoter]; Methylcholanthrene promotes the reaction [ARNT protein binds to CYP1A1 enhancer]; Methylcholanthrene results in increased activity of and results in increased expression of CYP1A1 protein; Methylcholanthrene results in increased expression of and results in increased activity of CYP1A1 protein; POR gene mutant form inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A1 protein] [[Methylcholanthrene results in increased expression of CYP1A1 protein] co-treated with [Methylcholanthrene results in increased expression of CYP1A2 protein]] results in decreased susceptibility to 3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole; [Methylcholanthrene co-treated with GNMT protein] results in increased expression of CYP1A1 mRNA; AHR protein affects the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; AHR protein promotes the reaction [Methylcholanthrene results in increased expression of and results in increased activity of CYP1A1 protein]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased acetylation of CYP1A1 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of CYP1A1 promoter]; Buthionine Sulfoximine inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A1 protein]; Dexamethasone promotes the reaction [Methylcholanthrene results in increased activity of CYP1A1 protein]; Ethoxyquin inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A1 protein]; herbimycin inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A1 protein]; isoimperatorin promotes the reaction [Methylcholanthrene results in increased expression of CYP1A1 protein]; lead nitrate inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 protein]; Methylcholanthrene promotes the reaction [CYP1A1 protein results in increased oxidation of Toluene]; Methylcholanthrene promotes the reaction [Hexachlorocyclohexane results in increased expression of and results in increased activity of CYP1A1 protein]; Methylcholanthrene results in increased expression of and results in increased activity of CYP1A1 protein; protocatechuic acid inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A1 protein]; sodium arsenite inhibits the reaction [Methylcholanthrene results in increased expression of and results in increased activity of CYP1A1 protein]; sodium arsenite inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA] CYP1A1 protein results in increased metabolism of Methylcholanthrene Methylcholanthrene results in increased activity of CYP1A1 promoter; Methylcholanthrene results in increased activity of CYP1A1 protein Methylcholanthrene results in decreased activity of CYP1A1 protein |
CTD RGD |
PMID:1316759 PMID:1617633 PMID:1994898 PMID:2154949 PMID:3785172 PMID:4054433 PMID:6749129 PMID:7238523 PMID:7493548 PMID:7756127 PMID:7980650 PMID:8163516 PMID:8902619 PMID:9152597 PMID:9233375 PMID:9261130 PMID:9783729 PMID:9860486 PMID:9973208 PMID:10329507 PMID:10476907 PMID:10772642 PMID:10799337 PMID:10859152 PMID:10872632 PMID:10874126 PMID:11158718 PMID:11285323 PMID:11328961 PMID:11356909 PMID:11502733 PMID:11768231 PMID:11999409 PMID:12107646 PMID:12117779 PMID:12458634 PMID:12490138 PMID:12490585 PMID:12505372 PMID:12700417 PMID:14672759 PMID:14987951 PMID:14993811 PMID:15297030 PMID:15302093 PMID:15337587 PMID:15350676 PMID:15448115 PMID:15521013 PMID:15582647 PMID:15585370 PMID:15590115 PMID:15620718 PMID:15621696 PMID:15860653 PMID:15885734 PMID:15946133 PMID:16137816 PMID:16167840 PMID:16257430 PMID:16359657 PMID:16489053 PMID:16619036 PMID:16639589 PMID:16829687 PMID:16906435 PMID:16968971 PMID:17069994 PMID:17230597 PMID:17253728 PMID:18486174 PMID:18493746 PMID:18502397 PMID:19022236 PMID:19043309 PMID:19118567 PMID:19525444 PMID:19853001 PMID:19883719 PMID:19889059 PMID:19951702 PMID:20020105 PMID:20067464 PMID:20171196 PMID:20226384 PMID:20348232 PMID:20350595 PMID:20570689 PMID:20570779 PMID:20713471 PMID:20816883 PMID:20881032 PMID:21250977 PMID:21292640 PMID:21498875 PMID:21666223 PMID:21800402 PMID:22507882 PMID:22761424 PMID:23169610 PMID:23273579 PMID:23712962 PMID:24091107 PMID:24486526 PMID:24999631 PMID:25174530 PMID:26006071 PMID:26651356 PMID:27055685 PMID:27163632 PMID:27590069 PMID:27644595 PMID:28601433 PMID:28887089 PMID:29094188 PMID:29554273 PMID:30503582 PMID:30842367 PMID:31776611 PMID:32726451 PMID:33811995 PMID:35149128 PMID:35487396 PMID:19889059 More...
|
RGD:401794453 |
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions increases response to substance increases expression increases activity affects response to substance |
ISO EXP |
[Celsior co-treated with Methylcholanthrene] results in increased expression of CYP1A2 mRNA; [Dexamethasone co-treated with Mifepristone] promotes the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein]; AHR protein affects the susceptibility to [Methylcholanthrene results in increased expression of CYP1A2 mRNA]; Dehydroepiandrosterone inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA]; Dexamethasone inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein]; Dexamethasone promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA]; Methylcholanthrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]; Methylcholanthrene promotes the reaction [Nicardipine results in increased expression of CYP1A2 mRNA]; Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA]]; Nicardipine promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA]; Oxygen deficiency inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA] CYP1A2 gene mutant form results in increased susceptibility to Methylcholanthrene Methylcholanthrene results in increased expression of CYP1A2 mRNA; Methylcholanthrene results in increased expression of CYP1A2 protein [Methylcholanthrene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A2 mRNA; AHR protein promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA]; AHR protein promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 protein]; CTNNB1 gene mutant form affects the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA]; CYP1A1 gene mutant form promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA]; CYP1A2 gene mutant form promotes the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA] [[Methylcholanthrene results in increased expression of CYP1A1 protein] co-treated with [Methylcholanthrene results in increased expression of CYP1A2 protein]] results in decreased susceptibility to 3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole; [Methylcholanthrene results in increased activity of CYP1A2 protein] which results in increased oxidation of Uroporphyrinogens; lead nitrate inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A2 protein]; Methylcholanthrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein]; Methylcholanthrene promotes the reaction [CYP1A2 protein results in increased oxidation of Toluene]; Methylcholanthrene promotes the reaction [Hexachlorocyclohexane results in increased expression of and results in increased activity of CYP1A2 protein]; Methylcholanthrene results in increased expression of and results in increased activity of CYP1A2 protein; protocatechuic acid inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein] CYP1A2 affects the susceptibility to Methylcholanthrene |
CTD |
PMID:1617633 PMID:1994898 PMID:3785172 PMID:4054433 PMID:6749129 PMID:7238523 PMID:7493548 PMID:8120057 PMID:8902619 PMID:9152597 PMID:9233375 PMID:9744552 PMID:9783729 PMID:10476907 PMID:10772642 PMID:11285323 PMID:11328961 PMID:11356909 PMID:11549291 PMID:11999409 PMID:12107646 PMID:12117779 PMID:15144902 PMID:15302093 PMID:15448115 PMID:15590115 PMID:15769886 PMID:15946133 PMID:16167840 PMID:16639589 PMID:18486174 PMID:18493746 PMID:19022236 PMID:19118567 PMID:19135037 PMID:19497360 PMID:19525444 PMID:19679878 PMID:19772856 PMID:19951702 PMID:20067464 PMID:20171196 PMID:20226384 PMID:20595379 PMID:20881032 PMID:21498875 PMID:23169610 PMID:23273579 PMID:23603339 PMID:25174530 PMID:27644595 PMID:27917125 PMID:28174063 PMID:28887089 PMID:30503582 PMID:30842367 PMID:31776611 PMID:32726451 PMID:33811995 More...
|
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
multiple interactions increases expression increases metabolic processing increases chemical synthesis |
ISO EXP |
Methylcholanthrene promotes the reaction [AHR protein binds to CYP1B1 promoter]; Methylcholanthrene promotes the reaction [ARNT protein binds to CYP1B1 promoter]; Methylcholanthrene promotes the reaction [Methylcholanthrene results in increased expression of CYP1B1 mRNA]; Methylcholanthrene results in increased expression of and results in increased activity of CYP1B1 protein; Nicardipine promotes the reaction [Methylcholanthrene results in increased expression of CYP1B1 mRNA] 3-methylcholanthrene increases expression of mRNA, protein in rat heart Methylcholanthrene results in increased expression of CYP1B1 mRNA; Methylcholanthrene results in increased expression of CYP1B1 protein alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of CYP1B1 mRNA] CYP1B1 protein results in increased metabolism of Methylcholanthrene CYP1B1 protein results in increased chemical synthesis of Methylcholanthrene metabolite |
CTD RGD |
PMID:9783729 PMID:10402558 PMID:11323195 PMID:11328961 PMID:11502733 PMID:11922910 PMID:12107646 PMID:12117779 PMID:15582647 PMID:15885734 PMID:17253728 PMID:19889059 PMID:19951702 PMID:20067464 PMID:20093341 PMID:20348232 PMID:20350595 PMID:20570779 PMID:20713471 PMID:20881032 PMID:23169610 PMID:23273579 PMID:23712962 PMID:27163632 PMID:28601433 PMID:28887089 PMID:29554273 PMID:35487396 PMID:19889059 More...
|
RGD:401794453 |
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [Calcitriol results in increased expression of CYP24A1 mRNA] |
CTD |
PMID:19244278 |
|
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
|
|
G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
increases expression |
EXP |
Methylcholanthrene results in increased expression of CYP2A1 mRNA |
CTD |
PMID:11323195 PMID:19118567 PMID:22934830 |
|
NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887
|
|
G |
Cyp2a2 |
cytochrome P450, family 2, subfamily a, polypeptide 2 |
decreases expression increases expression |
EXP |
Methylcholanthrene results in decreased expression of CYP2A2 mRNA Methylcholanthrene results in increased expression of CYP2A2 mRNA |
CTD |
PMID:11328961 PMID:22934830 PMID:23273579 |
|
NCBI chr 1:82,263,833...82,289,487
Ensembl chr 1:82,263,833...82,289,487
|
|
G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
multiple interactions increases expression |
ISO EXP |
Methylcholanthrene promotes the reaction [AHR protein binds to CYP2A7 promoter] Methylcholanthrene results in increased expression of CYP2A4 mRNA Methylcholanthrene results in increased expression of CYP2A3 mRNA |
CTD |
PMID:12845369 PMID:20348232 PMID:22934830 PMID:30503582 |
|
NCBI chr 1:82,171,914...82,179,980
Ensembl chr 1:82,169,949...82,179,979
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
multiple interactions decreases expression affects expression |
EXP ISO |
Methylcholanthrene promotes the reaction [Hexachlorocyclohexane results in increased expression of and results in increased activity of CYP2B1 protein] Methylcholanthrene results in decreased expression of CYP2B10 mRNA Methylcholanthrene affects the expression of CYP2B1 mRNA |
CTD |
PMID:18486174 PMID:23273579 PMID:30503582 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
multiple interactions affects expression |
EXP |
Methylcholanthrene promotes the reaction [Hexachlorocyclohexane results in increased expression of and results in increased activity of CYP2B2 protein] Methylcholanthrene affects the expression of CYP2B2 mRNA |
CTD |
PMID:18486174 PMID:23273579 |
|
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
decreases expression increases expression |
EXP ISO |
Methylcholanthrene results in decreased expression of CYP2B3 mRNA Methylcholanthrene results in increased expression of CYP2B9 mRNA |
CTD |
PMID:11328961 PMID:30503582 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
multiple interactions increases expression decreases expression |
EXP |
Methylcholanthrene promotes the reaction [CYP2C11 protein results in increased oxidation of Toluene] Methylcholanthrene results in increased expression of CYP2C11 mRNA Methylcholanthrene results in decreased expression of CYP2C11 mRNA |
CTD |
PMID:1994898 PMID:10476907 PMID:22978700 PMID:23273579 |
|
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
|
|
G |
Cyp2c13 |
cytochrome P450, family 2, subfamily c, polypeptide 13 |
increases expression |
EXP |
Methylcholanthrene results in increased expression of CYP2C13 protein |
CTD |
PMID:25786523 |
|
NCBI chr 1:238,786,764...238,867,195
Ensembl chr 1:238,786,765...238,867,191
|
|
G |
Cyp2c79 |
cytochrome P450, family 2, subfamily c, polypeptide 79 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of CYP2C29 mRNA |
CTD |
PMID:30503582 |
|
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
increases expression |
EXP |
Methylcholanthrene results in increased expression of CYP2D4 mRNA |
CTD |
PMID:11328961 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions increases expression decreases expression decreases activity |
EXP ISO |
[Acetone co-treated with Methylcholanthrene] results in decreased expression of CYP2E1 mRNA; [Acetone co-treated with Methylcholanthrene] results in decreased expression of CYP2E1 protein; [Acetone co-treated with Methylcholanthrene] results in increased activity of CYP2E1 protein; [Acetone co-treated with Methylcholanthrene] results in increased expression of CYP2E1 protein; [Methylcholanthrene results in decreased expression of CYP2E1 protein] which affects the metabolism of Benzene; [protocatechuic acid co-treated with Methylcholanthrene] results in decreased activity of CYP2E1 protein; [pyridine co-treated with Methylcholanthrene] results in decreased expression of CYP2E1 mRNA; [pyridine co-treated with Methylcholanthrene] results in decreased expression of CYP2E1 protein; [pyridine co-treated with Methylcholanthrene] results in increased activity of CYP2E1 protein; [pyridine co-treated with Methylcholanthrene] results in increased expression of CYP2E1 protein; Methylcholanthrene promotes the reaction [CYP2E1 protein results in increased oxidation of Toluene] 3-methylcholanthrene increases expression of mRNA, protein in rat heart Methylcholanthrene results in decreased expression of CYP2E1 mRNA Methylcholanthrene results in increased expression of CYP2E1 mRNA; Methylcholanthrene results in increased expression of CYP2E1 protein Methylcholanthrene results in decreased expression of CYP2E1 mRNA; Methylcholanthrene results in decreased expression of CYP2E1 protein Methylcholanthrene results in decreased activity of CYP2E1 protein |
CTD RGD |
PMID:1994898 PMID:3113478 PMID:7493548 PMID:8734847 PMID:9118891 PMID:10476907 PMID:15302093 PMID:19889059 PMID:23273579 PMID:28673560 PMID:30503582 PMID:19889059 More...
|
RGD:401794453 |
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp2s1 |
cytochrome P450, family 2, subfamily s, polypeptide 1 |
increases expression |
EXP |
Methylcholanthrene results in increased expression of CYP2S1 mRNA |
CTD |
PMID:19883719 |
|
NCBI chr 1:81,309,948...81,325,303
Ensembl chr 1:81,310,451...81,325,303
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions decreases expression increases expression |
EXP ISO |
Dactinomycin inhibits the reaction [Methylcholanthrene results in increased expression of CYP3A2 mRNA] [Methylcholanthrene co-treated with Rifampin co-treated with Phenobarbital] results in increased expression of CYP3A4 mRNA; Methylcholanthrene results in decreased expression of and results in decreased activity of CYP3A4 protein Methylcholanthrene results in decreased expression of CYP3A4 protein |
CTD |
PMID:10640517 PMID:11181506 PMID:23846873 PMID:24999631 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
increases expression |
EXP |
Methylcholanthrene results in increased expression of CYP3A23-3A1 mRNA |
CTD |
PMID:23273579 |
|
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
increases expression multiple interactions |
ISO |
Methylcholanthrene results in increased expression of CYP3A5 mRNA AHR protein affects the reaction [Methylcholanthrene results in increased expression of CYP3A5 mRNA] |
CTD |
PMID:33408298 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
increases expression increases expression |
EXP |
Methylcholanthrene results in increased expression of CYP4A3 mRNA 3-methylcholanthrene increases expression of mRNA in rat heart |
CTD RGD |
PMID:19889059 PMID:19889059 |
RGD:401794453 |
NCBI chr 5:129,097,571...129,115,488
Ensembl chr 5:129,097,926...129,115,463
|
|
G |
Cyp4b1 |
cytochrome P450, family 4, subfamily b, polypeptide 1 |
increases expression |
EXP |
Methylcholanthrene results in increased expression of CYP4B1 mRNA |
CTD |
PMID:23273579 |
|
NCBI chr 5:129,139,019...129,176,860
Ensembl chr 5:129,139,038...129,156,348
|
|
G |
Cyp4f4 |
cytochrome P450, family 4, subfamily f, polypeptide 4 |
increases expression increases expression |
EXP |
Methylcholanthrene results in increased expression of CYP4F4 mRNA 3-methylcholanthrene increases expression of mRNA in rat heart |
CTD RGD |
PMID:19889059 PMID:19889059 |
RGD:401794453 |
NCBI chr 7:11,717,208...11,733,507
Ensembl chr 7:11,717,208...11,733,506
|
|
G |
Cyp4f5 |
cytochrome P450, family 4, subfamily f, polypeptide 5 |
increases expression increases expression |
EXP |
Methylcholanthrene results in increased expression of CYP4F5 mRNA 3-methylcholanthrene increases expression of mRNA in rat heart |
CTD RGD |
PMID:19889059 PMID:19889059 |
RGD:401794453 |
NCBI chr 7:11,544,040...11,558,982
Ensembl chr 7:11,544,082...11,558,978
|
|
G |
Cyp4f6 |
cytochrome P450, family 4, subfamily f, polypeptide 6 |
decreases expression |
EXP |
Methylcholanthrene results in decreased expression of CYP4F6 mRNA |
CTD |
PMID:11328961 |
|
NCBI chr 7:12,030,276...12,058,020
Ensembl chr 7:12,030,301...12,057,782
|
|
G |
Dab2 |
DAB adaptor protein 2 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of DAB2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 2:55,514,692...55,567,476
Ensembl chr 2:55,514,700...55,567,476
|
|
G |
Dact1 |
dishevelled-binding antagonist of beta-catenin 1 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of DACT1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 6:89,790,676...89,818,254
Ensembl chr 6:89,790,644...89,817,906
|
|
G |
Dapk1 |
death associated protein kinase 1 |
multiple interactions |
EXP ISO |
[Diethylnitrosamine co-treated with Methylcholanthrene] results in decreased expression of DAPK1 protein; [Diethylnitrosamine co-treated with Methylcholanthrene] results in increased methylation of DAPK1 promoter [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of DAPK1 mRNA |
CTD |
PMID:20970405 PMID:23519560 |
|
NCBI chr17:3,930,223...4,090,991
Ensembl chr17:3,930,213...4,090,991
|
|
G |
Dapk2 |
death-associated protein kinase 2 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of DAPK2 mRNA |
CTD |
PMID:23519560 |
|
NCBI chr 8:66,706,536...66,825,567
Ensembl chr 8:66,706,609...66,825,567
|
|
G |
Dazl |
deleted in azoospermia-like |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of DAZL mRNA |
CTD |
PMID:35487396 |
|
NCBI chr 9:10,695,593...10,712,330
Ensembl chr 9:10,695,592...10,712,323
|
|
G |
Dbn1 |
drebrin 1 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of DBN1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr17:9,150,608...9,164,982
Ensembl chr17:9,150,659...9,164,984
|
|
G |
Dck |
deoxycytidine kinase |
increases expression |
ISO |
Methylcholanthrene results in increased expression of DCK mRNA |
CTD |
PMID:20713471 |
|
NCBI chr14:19,305,218...19,326,247
Ensembl chr14:19,305,218...19,326,247
|
|
G |
Dclk1 |
doublecortin-like kinase 1 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of DCLK1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 2:139,417,234...139,710,956
Ensembl chr 2:139,417,163...139,710,956
|
|
G |
Ddr2 |
discoidin domain receptor tyrosine kinase 2 |
multiple interactions increases expression |
EXP |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of DDR2 mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr13:82,193,623...82,318,229
Ensembl chr13:82,195,463...82,317,363
|
|
G |
Ddx17 |
DEAD-box helicase 17 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of DDX17 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 7:111,091,127...111,109,353
Ensembl chr 7:111,089,445...111,109,193
|
|
G |
Ddx4 |
DEAD-box helicase 4 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of DDX4 mRNA |
CTD |
PMID:35487396 |
|
NCBI chr 2:44,227,946...44,282,867
Ensembl chr 2:44,227,946...44,282,723
|
|
G |
Ddx5 |
DEAD-box helicase 5 |
multiple interactions increases expression |
EXP |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of DDX5 mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr10:91,723,508...91,732,210
Ensembl chr10:91,723,508...91,732,283
|
|
G |
Degs1 |
delta(4)-desaturase, sphingolipid 1 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to DEGS1 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr13:93,946,154...93,953,677
Ensembl chr13:93,946,157...93,953,664
|
|
G |
Depdc1 |
DEP domain containing 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of DEPDC1A mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 2:248,684,508...248,717,951
Ensembl chr 2:248,684,523...248,717,951
|
|
G |
Depdc1b |
DEP domain containing 1B |
increases expression |
ISO |
Methylcholanthrene results in increased expression of DEPDC1B mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 2:39,891,163...39,963,779
Ensembl chr 2:39,891,481...39,963,779
|
|
G |
Deptor |
DEP domain containing MTOR-interacting protein |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of DEPTOR mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 7:86,514,859...86,668,817
Ensembl chr 7:86,514,988...86,667,773
|
|
G |
Dhfr |
dihydrofolate reductase |
increases expression |
ISO |
Methylcholanthrene results in increased expression of DHFR mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
|
|
G |
Diaph1 |
diaphanous-related formin 1 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to DIAPH1 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr18:29,669,659...29,769,070
Ensembl chr18:29,669,659...29,769,172
|
|
G |
Dlgap5 |
DLG associated protein 5 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of DLGAP5 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr15:20,633,964...20,664,569
Ensembl chr15:20,633,966...20,664,518
|
|
G |
Dll1 |
delta like canonical Notch ligand 1 |
increases expression multiple interactions |
EXP |
Methylcholanthrene results in increased expression of DLL1 mRNA alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of DLL1 mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr 1:56,312,062...56,320,177
Ensembl chr 1:56,312,066...56,320,179
|
|
G |
Dmp1 |
dentin matrix acidic phosphoprotein 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of DMP1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr14:5,528,441...5,542,078
Ensembl chr14:5,528,431...5,539,323
|
|
G |
Dnajb6 |
DnaJ heat shock protein family (Hsp40) member B6 |
multiple interactions increases acetylation increases methylation increases expression |
EXP |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to DNAJB6 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased acetylation of DNAJB6 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of DNAJB6 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of DNAJB6 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to DNAJB6 promoter] |
CTD |
PMID:29094188 |
|
NCBI chr 4:5,452,683...5,556,679
Ensembl chr 4:5,452,683...5,556,659
|
|
G |
Dnajc9 |
DnaJ heat shock protein family (Hsp40) member C9 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of DNAJC9 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr15:3,923,842...3,928,118
Ensembl chr15:3,923,268...3,928,118
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with Methylcholanthrene] affects the expression of and affects the localization of DNMT1 protein |
CTD |
PMID:21163286 |
|
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Dnmt3a |
DNA methyltransferase 3 alpha |
multiple interactions |
EXP |
[Diethylnitrosamine co-treated with Methylcholanthrene] affects the expression of and affects the localization of DNMT3A protein |
CTD |
PMID:21163286 |
|
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
|
|
G |
Dtl |
denticleless E3 ubiquitin protein ligase homolog |
increases expression |
ISO |
Methylcholanthrene results in increased expression of DTL mRNA |
CTD |
PMID:20713471 |
|
NCBI chr13:103,115,810...103,155,029
Ensembl chr13:103,117,186...103,154,890
|
|
G |
Dtna |
dystrobrevin, alpha |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to DTNA promoter] |
CTD |
PMID:20348232 |
|
NCBI chr18:14,687,193...14,944,232
Ensembl chr18:14,587,852...14,944,261
|
|
G |
Dusp14 |
dual specificity phosphatase 14 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to DUSP14 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr10:68,936,483...68,966,347
Ensembl chr10:68,935,330...68,965,329
|
|
G |
Dusp4 |
dual specificity phosphatase 4 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of DUSP4 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr16:57,376,659...57,398,161
Ensembl chr16:57,377,229...57,398,138
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of DUSP6 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
|
|
G |
Dut |
deoxyuridine triphosphatase |
increases expression |
ISO |
Methylcholanthrene results in increased expression of DUT mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 3:112,498,864...112,509,994
Ensembl chr 3:112,498,982...112,510,771
|
|
G |
Dyrk2 |
dual specificity tyrosine phosphorylation regulated kinase 2 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of DYRK2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 7:54,348,724...54,381,363
Ensembl chr 7:54,349,610...54,380,106
|
|
G |
E2f7 |
E2F transcription factor 7 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of E2F7 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 7:46,150,533...46,192,739
Ensembl chr 7:46,151,293...46,192,734
|
|
G |
E2f8 |
E2F transcription factor 8 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of E2F8 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
|
|
G |
Ecm1 |
extracellular matrix protein 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ECM1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 2:183,287,491...183,292,729
Ensembl chr 2:183,287,322...183,292,671
|
|
G |
Ect2 |
epithelial cell transforming 2 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ECT2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 2:109,975,813...110,037,911
Ensembl chr 2:109,975,813...110,037,911
|
|
G |
Efna5 |
ephrin A5 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of EFNA5 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 9:102,316,753...102,595,480
Ensembl chr 9:102,320,295...102,597,413
|
|
G |
Efnb1 |
ephrin B1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of EFNB1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr X:64,257,351...64,270,158
Ensembl chr X:64,257,351...64,270,157
|
|
G |
Egfr |
epidermal growth factor receptor |
decreases expression |
EXP |
Methylcholanthrene results in decreased expression of EGFR mRNA |
CTD |
PMID:29094188 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egr2 |
early growth response 2 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of EGR2 mRNA |
CTD |
PMID:29554273 |
|
NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
|
|
G |
Egr3 |
early growth response 3 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of EGR3 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr15:45,150,335...45,156,052
Ensembl chr15:45,150,567...45,154,627
|
|
G |
Ehd3 |
EH-domain containing 3 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to EHD3 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 6:21,640,861...21,665,601
Ensembl chr 6:21,639,290...21,665,236
|
|
G |
Eif1ax |
eukaryotic translation initiation factor 1A, X-linked |
increases expression |
ISO |
Methylcholanthrene results in increased expression of EIF1AY mRNA |
CTD |
PMID:20713471 |
|
NCBI chr X:35,498,698...35,513,402
Ensembl chr X:35,498,517...35,513,335
|
|
G |
Eif2b2 |
eukaryotic translation initiation factor 2B subunit beta |
increases expression |
ISO |
Methylcholanthrene results in increased expression of EIF2B2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 6:104,866,926...104,873,351
Ensembl chr 6:104,866,753...104,873,353
|
|
G |
Eif4e1b |
eukaryotic translation initiation factor 4E family member 1B |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of EIF4E1B mRNA |
CTD |
PMID:23519560 |
|
NCBI chr17:9,831,338...9,856,250
Ensembl chr17:9,832,230...9,835,137
|
|
G |
Eif4ebp2 |
eukaryotic translation initiation factor 4E binding protein 2 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of EIF4EBP2 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr20:29,379,444...29,400,110
Ensembl chr20:29,382,668...29,399,946
|
|
G |
Elmo1 |
engulfment and cell motility 1 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of ELMO1 mRNA |
CTD |
PMID:23519560 |
|
NCBI chr17:44,286,495...44,822,668
Ensembl chr17:44,286,485...44,822,788
|
|
G |
Elovl3 |
ELOVL fatty acid elongase 3 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ELOVL3 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 1:244,997,287...245,001,115
Ensembl chr 1:244,997,287...245,001,115
|
|
G |
Eme1 |
essential meiotic structure-specific endonuclease 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of EME1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr10:79,586,718...79,595,515
Ensembl chr10:79,586,729...79,595,435
|
|
G |
Emp1 |
epithelial membrane protein 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of EMP1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 4:168,212,901...168,233,039
Ensembl chr 4:168,212,861...168,232,904
|
|
G |
Enpep |
glutamyl aminopeptidase |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of ENPEP mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 2:217,781,985...217,851,947
Ensembl chr 2:217,782,005...217,851,947
|
|
G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of ENPP2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of EPAS1 mRNA |
CTD |
PMID:23519560 |
|
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
|
|
G |
Ephb6 |
Eph receptor B6 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of EPHB6 mRNA |
CTD |
PMID:23519560 |
|
NCBI chr 4:70,491,973...70,507,230
Ensembl chr 4:70,491,973...70,507,230
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
increases activity increases expression |
ISO EXP |
Methylcholanthrene results in increased activity of EPHX1 protein Methylcholanthrene results in increased expression of EPHX1 mRNA |
CTD |
PMID:3621371 PMID:23273579 |
|
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
increases activity increases expression decreases activity |
EXP ISO |
Methylcholanthrene results in increased activity of EPHX2 protein 3-methylcholanthrene increases expression of mRNA, protein in rat heart Methylcholanthrene results in decreased activity of EPHX2 protein Methylcholanthrene results in increased expression of EPHX2 mRNA; Methylcholanthrene results in increased expression of EPHX2 protein |
CTD RGD |
PMID:3621371 PMID:19889059 PMID:19889059 |
RGD:401794453 |
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
|
|
G |
Eps15 |
epidermal growth factor receptor pathway substrate 15 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to EPS15 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 5:124,045,865...124,146,221
Ensembl chr 5:124,045,926...124,146,221
|
|
G |
Eps8 |
epidermal growth factor receptor pathway substrate 8 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of EPS8 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 4:170,388,378...170,486,873
Ensembl chr 4:170,388,378...170,486,873
|
|
G |
Ercc6 |
ERCC excision repair 6, chromatin remodeling factor |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to ERCC6 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr16:7,764,983...7,835,587
Ensembl chr16:7,765,013...7,835,587
|
|
G |
Ercc6l |
ERCC excision repair 6 like, spindle assembly checkpoint helicase |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ERCC6L mRNA |
CTD |
PMID:20713471 |
|
NCBI chr X:67,245,414...67,261,222
Ensembl chr X:67,245,414...67,280,756
|
|
G |
Ereg |
epiregulin |
increases expression |
ISO |
Methylcholanthrene results in increased expression of EREG mRNA |
CTD |
PMID:20713471 |
|
NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
|
|
G |
Esco2 |
establishment of sister chromatid cohesion N-acetyltransferase 2 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ESCO2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr15:40,034,566...40,052,295
Ensembl chr15:40,034,568...40,055,306
|
|
G |
Espl1 |
extra spindle pole bodies like 1, separase |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ESPL1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 7:133,424,027...133,450,984
Ensembl chr 7:133,424,130...133,450,984
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions decreases expression increases expression increases activity affects binding |
ISO EXP |
Fulvestrant inhibits the reaction [Methylcholanthrene results in increased expression of ESR1 mRNA]; Methylcholanthrene binds to and results in increased activity of ESR1 protein; Methylcholanthrene promotes the reaction [AHR protein binds to ESR1 promoter]; Methylcholanthrene promotes the reaction [ARNT protein binds to ESR1 promoter]; Methylcholanthrene promotes the reaction [ESR1 protein binds to CYP1A1 promoter] alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased expression of ESR1 mRNA] Methylcholanthrene results in increased activity of ESR1 protein Methylcholanthrene binds to ESR1 protein |
CTD |
PMID:16257430 PMID:16489053 PMID:16972788 PMID:20348232 PMID:23273579 PMID:29094188 More...
|
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Etv1 |
ETS variant transcription factor 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ETV1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 6:55,590,149...55,681,784
Ensembl chr 6:55,590,234...55,681,775
|
|
G |
Etv5 |
ETS variant transcription factor 5 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ETV5 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr11:78,608,618...78,666,221
Ensembl chr11:78,608,710...78,666,215
|
|
G |
Exo1 |
exonuclease 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of EXO1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr13:87,809,725...87,834,654
Ensembl chr13:87,809,810...87,834,654
|
|
G |
Exosc9 |
exosome component 9 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to EXOSC9 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 2:119,416,028...119,426,981
Ensembl chr 2:119,388,715...119,427,051
|
|
G |
F11r |
F11 receptor |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of F11R mRNA |
CTD |
PMID:23519560 |
|
NCBI chr13:83,873,797...83,897,388
Ensembl chr13:83,873,797...83,897,402
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
decreases expression multiple interactions |
ISO |
Methylcholanthrene results in decreased expression of FABP4 mRNA [Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of FABP4 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fas |
Fas cell surface death receptor |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of FAS mRNA |
CTD |
PMID:23519560 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fcar |
Fc alpha receptor |
increases expression |
ISO |
Methylcholanthrene results in increased expression of FCAR mRNA |
CTD |
PMID:21911031 |
|
NCBI chr 1:69,626,458...69,660,558
|
|
G |
Fchsd2 |
FCH and double SH3 domains 2 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of FCHSD2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 1:155,444,471...155,685,350
Ensembl chr 1:155,444,460...155,685,539
|
|
G |
Fcrl5 |
Fc receptor-like 5 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of FCRL5 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 2:172,881,763...172,912,912
Ensembl chr 2:172,881,448...172,913,148
|
|
G |
Fdps |
farnesyl diphosphate synthase |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of FDPS mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
|
|
G |
Fdxr |
ferredoxin reductase |
increases expression |
ISO |
Methylcholanthrene results in increased expression of FDXR mRNA |
CTD |
PMID:22100608 |
|
NCBI chr10:100,507,863...100,516,649
Ensembl chr10:100,507,865...100,516,658
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of FGF1 mRNA |
CTD |
PMID:23519560 |
|
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
|
|
G |
Fgf10 |
fibroblast growth factor 10 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of FGF10 mRNA |
CTD |
PMID:23519560 |
|
NCBI chr 2:50,801,171...50,878,218
Ensembl chr 2:50,800,992...50,876,866
|
|
G |
Fgf18 |
fibroblast growth factor 18 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of FGF18 mRNA |
CTD |
PMID:23519560 |
|
NCBI chr10:17,706,011...17,737,702
Ensembl chr10:17,706,174...17,736,818
|
|
G |
Fgf7 |
fibroblast growth factor 7 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of FGF7 mRNA |
CTD |
PMID:23519560 |
|
NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of FGFR1 mRNA |
CTD |
PMID:20713471 PMID:29554273 |
|
NCBI chr16:66,491,930...66,547,161
Ensembl chr16:66,494,042...66,547,350
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of FGFR2 mRNA |
CTD |
PMID:23519560 |
|
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Fhit |
fragile histidine triad diadenosine triphosphatase |
multiple interactions decreases expression |
EXP ISO |
[Diethylnitrosamine co-treated with Methylcholanthrene] results in decreased expression of FHIT protein; [Diethylnitrosamine co-treated with Methylcholanthrene] results in increased methylation of FHIT promoter Methylcholanthrene results in decreased expression of FHIT mRNA |
CTD |
PMID:20970405 PMID:22100608 |
|
NCBI chr15:13,935,029...15,442,620
Ensembl chr15:13,934,995...15,442,340
|
|
G |
Fignl1 |
fidgetin-like 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of FIGNL1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr14:86,368,670...86,381,728
Ensembl chr14:86,368,675...86,377,455
|
|
G |
Fmo2 |
flavin containing dimethylaniline monoxygenase 2 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of FMO2 mRNA |
CTD |
PMID:20570689 |
|
NCBI chr13:75,221,149...75,244,377
Ensembl chr13:75,224,402...75,244,308
|
|
G |
Fmo3 |
flavin containing dimethylaniline monoxygenase 3 |
multiple interactions decreases expression increases expression |
ISO EXP |
AHR protein affects the reaction [Methylcholanthrene results in increased expression of FMO3 mRNA]; Methylcholanthrene promotes the reaction [TRP53 protein binds to FMO3 5' UTR] Methylcholanthrene results in decreased expression of FMO3 mRNA |
CTD |
PMID:20570689 PMID:23273579 PMID:23846873 PMID:25926378 |
|
NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028
|
|
G |
Fmod |
fibromodulin |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of FMOD mRNA |
CTD |
PMID:20713471 |
|
NCBI chr13:45,493,517...45,504,134
Ensembl chr13:45,493,517...45,504,133
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
increases expression |
ISO |
Methylcholanthrene results in increased expression of FOSL1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
|
|
G |
Foxm1 |
forkhead box M1 |
affects response to substance |
ISO |
FOXM1 protein affects the susceptibility to Methylcholanthrene |
CTD |
PMID:18345025 PMID:19672312 |
|
NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684
|
|
G |
Foxn1 |
forkhead box N1 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to FOXN1 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr10:63,251,400...63,273,710
Ensembl chr10:63,251,400...63,273,710
|
|
G |
Foxn3 |
forkhead box N3 |
multiple interactions increases expression |
EXP |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of FOXN3 mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr 6:118,462,018...118,842,442
Ensembl chr 6:118,466,025...118,842,401
|
|
G |
Foxn4 |
forkhead box N4 |
multiple interactions increases expression |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to FOXN4 promoter]; Methylcholanthrene promotes the reaction [ARNT protein binds to FOXN4 promoter]; Methylcholanthrene promotes the reaction [Methylcholanthrene results in increased expression of FOXN4 mRNA] |
CTD |
PMID:20348232 |
|
NCBI chr12:42,336,706...42,359,932
Ensembl chr12:42,340,323...42,359,921
|
|
G |
Foxo3 |
forkhead box O3 |
multiple interactions |
EXP |
[Methylcholanthrene co-treated with alpha-naphthoflavone] results in increased expression of FOXO3 mRNA |
CTD |
PMID:29094188 |
|
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
|
|
G |
Frem2 |
FRAS1 related extracellular matrix 2 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to FREM2 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 2:137,602,784...137,740,785
Ensembl chr 2:137,602,784...137,740,785
|
|
G |
Fryl |
FRY like transcription coactivator |
increases expression |
ISO |
Methylcholanthrene results in increased expression of FRYL mRNA |
CTD |
PMID:20713471 |
|
NCBI chr14:34,956,623...35,189,738
Ensembl chr14:34,956,620...35,190,222
|
|
G |
Fst |
follistatin |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of FST mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 2:46,123,260...46,130,584
Ensembl chr 2:46,123,439...46,130,571
|
|
G |
Fstl1 |
follistatin-like 1 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of FSTL1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr11:62,895,391...62,948,581
Ensembl chr11:62,779,783...62,948,677
|
|
G |
Fut8 |
fucosyltransferase 8 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of FUT8 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 6:95,949,246...96,176,677
Ensembl chr 6:95,949,991...96,176,677
|
|
G |
Fxyd5 |
FXYD domain-containing ion transport regulator 5 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of FXYD5 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 1:86,267,937...86,277,329
Ensembl chr 1:86,267,406...86,277,519
|
|
G |
Fyn |
FYN proto-oncogene, Src family tyrosine kinase |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of FYN mRNA |
CTD |
PMID:23519560 |
|
NCBI chr20:42,767,733...42,960,903
Ensembl chr20:42,766,369...42,959,911
|
|
G |
Gab2 |
GRB2-associated binding protein 2 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of GAB2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 1:151,429,844...151,625,708
Ensembl chr 1:151,429,695...151,625,031
|
|
G |
Gabra3 |
gamma-aminobutyric acid type A receptor subunit alpha 3 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of GABRA3 mRNA |
CTD |
PMID:23519560 |
|
NCBI chr X:150,244,745...150,501,566
Ensembl chr X:150,261,607...150,501,559
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of GADD45A mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Galnt15 |
polypeptide N-acetylgalactosaminyltransferase 15 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of GALNT15 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr16:7,227,232...7,267,002
Ensembl chr16:7,227,271...7,267,014
|
|
G |
Galnt18 |
polypeptide N-acetylgalactosaminyltransferase 18 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of GALNT18 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 1:165,593,180...165,904,268
Ensembl chr 1:165,593,187...165,904,268
|
|
G |
Galnt7 |
polypeptide N-acetylgalactosaminyltransferase 7 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of GALNT7 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr16:32,578,643...32,703,189
Ensembl chr16:32,578,690...32,702,690
|
|
G |
Gas2l3 |
growth arrest-specific 2 like 3 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of GAS2L3 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 7:23,803,578...23,836,816
Ensembl chr 7:23,806,310...23,836,411
|
|
G |
Gata6 |
GATA binding protein 6 |
multiple interactions increases activity |
ISO |
Methylcholanthrene promotes the reaction [GATA6 protein binds to KRAS exon] Methylcholanthrene results in increased activity of GATA6 protein |
CTD |
PMID:16271038 |
|
NCBI chr18:2,188,121...2,219,532
Ensembl chr18:2,188,121...2,219,532
|
|
G |
Gcat |
glycine C-acetyltransferase |
increases expression |
ISO |
Methylcholanthrene results in increased expression of GCAT mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 7:110,595,126...110,601,474
Ensembl chr 7:110,595,091...110,601,473
|
|
G |
Gch1 |
GTP cyclohydrolase 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of GCH1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
|
|
G |
Gchfr |
GTP cyclohydrolase I feedback regulator |
increases expression |
ISO |
Methylcholanthrene results in increased expression of GCHFR mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 3:106,158,046...106,162,080
Ensembl chr 3:106,159,394...106,162,080
|
|
G |
Gdf9 |
growth differentiation factor 9 |
multiple interactions |
EXP |
[Methylcholanthrene co-treated with alpha-naphthoflavone] results in increased expression of GDF9 mRNA |
CTD |
PMID:29094188 |
|
NCBI chr10:37,589,200...37,599,970
Ensembl chr10:37,595,679...37,599,672
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of GDNF mRNA |
CTD |
PMID:35487396 |
|
NCBI chr 2:56,894,022...56,919,935
Ensembl chr 2:56,895,010...56,917,209
|
|
G |
Gdpd4 |
glycerophosphodiester phosphodiesterase domain containing 4 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to GDPD4 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 1:152,233,516...152,342,329
Ensembl chr 1:152,233,499...152,342,158
|
|
G |
Gh1 |
growth hormone 1 |
decreases activity |
EXP |
Methylcholanthrene results in decreased activity of GH1 protein |
CTD |
PMID:22978700 |
|
NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078
|
|
G |
Ghr |
growth hormone receptor |
decreases expression increases expression |
ISO |
Methylcholanthrene results in decreased expression of GHR mRNA Methylcholanthrene results in increased expression of GHR protein |
CTD |
PMID:22978700 PMID:23169610 |
|
NCBI chr 2:52,541,452...52,804,960
Ensembl chr 2:52,542,594...52,804,735
|
|
G |
Gins3 |
GINS complex subunit 3 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of GINS3 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr19:9,420,085...9,428,621
Ensembl chr19:9,420,086...9,428,687
|
|
G |
Gins4 |
GINS complex subunit 4 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of GINS4 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr16:68,787,572...68,799,938
Ensembl chr16:68,767,339...68,802,273
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of GJA1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gmnn |
geminin, DNA replication inhibitor |
increases expression |
ISO |
Methylcholanthrene results in increased expression of GMNN mRNA |
CTD |
PMID:20713471 |
|
NCBI chr17:40,301,771...40,310,054
Ensembl chr17:40,301,808...40,310,054
|
|
G |
Gnb4 |
G protein subunit beta 4 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of GNB4 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 2:115,360,746...115,400,680
Ensembl chr 2:115,364,918...115,400,579
|
|
G |
Gnmt |
glycine N-methyltransferase |
decreases expression multiple interactions |
ISO EXP |
Methylcholanthrene results in decreased expression of GNMT mRNA [Methylcholanthrene co-treated with GNMT protein] results in increased expression of CYP1A1 mRNA |
CTD |
PMID:9261130 PMID:22100608 |
|
NCBI chr 9:14,254,675...14,258,028
Ensembl chr 9:14,254,675...14,258,434
|
|
G |
Gpc1 |
glypican 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of GPC1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 9:93,396,234...93,424,047
Ensembl chr 9:93,396,234...93,424,047
|
|
G |
Gpcpd1 |
glycerophosphocholine phosphodiesterase 1 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of GPCPD1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 3:119,787,681...119,832,550
Ensembl chr 3:119,787,682...119,832,517
|
|
G |
Gphb5 |
glycoprotein hormone subunit beta 5 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to GPHB5 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 6:94,129,968...94,134,585
Ensembl chr 6:94,131,021...94,133,570
|
|
G |
Gpnmb |
glycoprotein nmb |
increases expression |
ISO |
Methylcholanthrene results in increased expression of GPNMB mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 4:78,010,247...78,031,491
Ensembl chr 4:78,010,197...78,049,367
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
increases expression |
EXP ISO |
Methylcholanthrene results in increased expression of GPX1 mRNA |
CTD |
PMID:23273579 PMID:23712962 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Greb1 |
growth regulating estrogen receptor binding 1 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to GREB1 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633
|
|
G |
Gria3 |
glutamate ionotropic receptor AMPA type subunit 3 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of GRIA3 mRNA |
CTD |
PMID:23519560 |
|
NCBI chr X:120,238,515...120,504,106
Ensembl chr X:120,238,534...120,504,096
|
|
G |
Grik4 |
glutamate ionotropic receptor kainate type subunit 4 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to GRIK4 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 8:42,903,043...43,331,990
Ensembl chr 8:42,905,056...43,193,751
|
|
G |
Grik5 |
glutamate ionotropic receptor kainate type subunit 5 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of GRIK5 mRNA |
CTD |
PMID:23519560 |
|
NCBI chr 1:80,605,878...80,667,896
Ensembl chr 1:80,605,892...80,667,125
|
|
G |
Gsdmc |
gasdermin C |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to GSDMC promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 7:95,594,015...95,606,106
Ensembl chr 7:95,594,015...95,611,344
|
|
G |
Gsdmd |
gasdermin D |
increases expression |
ISO |
Methylcholanthrene results in increased expression of GSDMD mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 7:107,542,489...107,547,051
Ensembl chr 7:107,542,083...107,547,055
|
|
G |
Gsdme |
gasdermin E |
increases expression |
ISO |
Methylcholanthrene results in increased expression of GSDME mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 4:79,258,799...79,321,129
Ensembl chr 4:79,257,804...79,320,806
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases activity increases expression |
ISO |
Methylcholanthrene results in increased activity of GSR protein Methylcholanthrene results in increased expression of GSR mRNA |
CTD |
PMID:23712962 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gss |
glutathione synthetase |
increases activity increases expression |
ISO |
Methylcholanthrene results in increased activity of GSS protein Methylcholanthrene results in increased expression of GSS mRNA |
CTD |
PMID:23712962 |
|
NCBI chr 3:144,047,849...144,078,197
Ensembl chr 3:144,047,850...144,078,198
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
increases expression multiple interactions decreases expression |
EXP ISO |
Methylcholanthrene results in increased expression of GSTA2 mRNA [Methylcholanthrene co-treated with Copper] results in increased activity of GSTA2 protein; Copper inhibits the reaction [Methylcholanthrene results in increased expression of GSTA2 mRNA]; Lead inhibits the reaction [Methylcholanthrene results in increased expression of GSTA2 mRNA]; Mercury promotes the reaction [Methylcholanthrene results in increased expression of GSTA2 mRNA] Methylcholanthrene results in decreased expression of GSTA2 mRNA |
CTD |
PMID:10476907 PMID:11328961 PMID:15297030 PMID:23273579 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of GSTA1 mRNA |
CTD |
PMID:23712962 |
|
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
|
|
G |
Gstk1 |
glutathione S-transferase kappa 1 |
increases expression |
EXP |
Methylcholanthrene results in increased expression of GSTK1 mRNA |
CTD |
PMID:23273579 |
|
NCBI chr 4:71,118,979...71,123,298
Ensembl chr 4:71,118,896...71,123,292
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
increases expression |
EXP |
Methylcholanthrene results in increased expression of GSTM1 mRNA |
CTD |
PMID:11328961 PMID:23273579 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
increases expression |
EXP |
Methylcholanthrene results in increased expression of GSTP1 mRNA |
CTD |
PMID:19118567 PMID:23273579 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gtse1 |
G-2 and S-phase expressed 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of GTSE1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 7:116,949,997...116,966,826
Ensembl chr 7:116,950,053...116,966,806
|
|
G |
Gulp1 |
GULP PTB domain containing engulfment adaptor 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of GULP1 mRNA |
CTD |
PMID:23397585 |
|
NCBI chr 9:46,622,699...46,899,005
Ensembl chr 9:46,622,669...46,899,005
|
|
G |
H2bc1 |
H2B clustered histone 1 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to H2BC1 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr17:41,172,041...41,172,510
Ensembl chr17:41,171,903...41,176,782 Ensembl chr17:41,171,903...41,176,782
|
|
G |
H3f3b |
H3.3 histone B |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of H3F3B mRNA |
CTD |
PMID:20713471 |
|
NCBI chr10:101,256,484...101,258,716
Ensembl chr10:101,256,480...101,258,709
|
|
G |
Hacd4 |
3-hydroxyacyl-CoA dehydratase 4 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of HACD4 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 5:102,887,597...102,915,376
Ensembl chr 5:102,887,588...102,915,338
|
|
G |
Haspin |
histone H3 associated protein kinase |
increases expression |
ISO |
Methylcholanthrene results in increased expression of HASPIN mRNA |
CTD |
PMID:20713471 |
|
NCBI chr10:57,747,731...57,750,518
Ensembl chr10:57,747,573...57,750,512
|
|
G |
Hba-a1 |
hemoglobin alpha, adult chain 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of HBA-A1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr10:15,337,265...15,338,121
Ensembl chr10:15,307,815...15,338,392
|
|
G |
Hck |
HCK proto-oncogene, Src family tyrosine kinase |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of HCK mRNA |
CTD |
PMID:23519560 |
|
NCBI chr 3:141,571,587...141,614,696
Ensembl chr 3:141,571,587...141,614,693
|
|
G |
Hcrtr2 |
hypocretin receptor 2 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to HCRTR2 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 8:76,989,834...77,105,953
Ensembl chr 8:76,989,834...77,105,893
|
|
G |
Hdac11 |
histone deacetylase 11 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to HDAC11 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 4:123,645,873...123,667,407
Ensembl chr 4:123,650,157...123,667,405
|
|
G |
Hdac5 |
histone deacetylase 5 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of HDAC5 mRNA |
CTD |
PMID:29554273 |
|
NCBI chr10:87,152,978...87,187,921
Ensembl chr10:87,152,978...87,188,235
|
|
G |
Heph |
hephaestin |
increases expression |
ISO |
Methylcholanthrene results in increased expression of HEPH mRNA |
CTD |
PMID:20713471 |
|
NCBI chr X:61,151,131...61,402,980
Ensembl chr X:61,296,345...61,402,980
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
multiple interactions increases expression |
EXP |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to HES1 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of HES1 mRNA]; Methylcholanthrene promotes the reaction [AHR protein binds to HES1 promoter] |
CTD |
PMID:29094188 |
|
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
|
|
G |
Hgf |
hepatocyte growth factor |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of HGF mRNA |
CTD |
PMID:23519560 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hhip |
Hedgehog-interacting protein |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of HHIP mRNA |
CTD |
PMID:23519560 |
|
NCBI chr19:27,863,684...27,952,528
Ensembl chr19:27,863,213...27,952,528
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
increases expression |
EXP |
Methylcholanthrene results in increased expression of HIF1A mRNA |
CTD |
PMID:23273579 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hipk2 |
homeodomain interacting protein kinase 2 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of HIPK2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 4:67,439,327...67,619,223
Ensembl chr 4:67,440,501...67,619,223
|
|
G |
Hist1h2bc |
histone cluster 1, H2bc |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to H2BC21 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr17:42,692,335...42,696,601
Ensembl chr17:42,694,723...42,696,642
|
|
G |
Hmga1 |
high mobility group AT-hook 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of HMGA1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr20:5,611,088...5,618,755
Ensembl chr20:5,611,694...5,618,752
|
|
G |
Hmga2 |
high mobility group AT-hook 2 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of HMGA2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 7:55,877,145...55,998,813
Ensembl chr 7:55,880,112...55,994,784
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of HMGCR mRNA |
CTD |
PMID:35487396 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of HMGCS1 mRNA |
CTD |
PMID:20713471 PMID:35487396 |
|
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
|
|
G |
Hmmr |
hyaluronan-mediated motility receptor |
increases expression |
ISO |
Methylcholanthrene results in increased expression of HMMR mRNA |
CTD |
PMID:20713471 |
|
NCBI chr10:25,132,933...25,163,029
Ensembl chr10:25,132,977...25,163,060
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression |
ISO EXP |
[Methylcholanthrene co-treated with Copper] results in increased expression of HMOX1 mRNA; [Methylcholanthrene co-treated with Lead] results in increased expression of HMOX1 mRNA; [Methylcholanthrene co-treated with Mercury] results in increased expression of HMOX1 mRNA Methylcholanthrene results in increased expression of HMOX1 mRNA |
CTD |
PMID:15297030 PMID:19889059 PMID:22100608 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
multiple interactions |
ISO |
[Butylated Hydroxytoluene co-treated with Methylcholanthrene] affects the localization of HNRNPA1 protein; [Butylated Hydroxytoluene co-treated with Methylcholanthrene] results in increased expression of HNRNPA1 protein |
CTD |
PMID:15390079 |
|
NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
|
|
G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Butylated Hydroxytoluene] affects the expression of HNRNPA2B1 protein |
CTD |
PMID:17477362 |
|
NCBI chr 4:80,534,659...80,545,297
Ensembl chr 4:80,534,651...80,545,249
|
|
G |
Hoxc10 |
homeo box C10 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of HOXC10 mRNA |
CTD |
PMID:20348232 |
|
NCBI chr 7:134,103,741...134,108,966
Ensembl chr 7:134,103,643...134,108,966
|
|
G |
Hoxc11 |
homeobox C11 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to HOXC11 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 7:134,091,224...134,094,738
Ensembl chr 7:134,091,552...134,094,738
|
|
G |
Hpcal4 |
hippocalcin-like 4 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of HPCAL4 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 5:135,454,477...135,466,417
Ensembl chr 5:135,454,540...135,466,416
|
|
G |
Hpgd |
15-hydroxyprostaglandin dehydrogenase |
increases expression |
ISO |
Methylcholanthrene results in increased expression of HPGD mRNA |
CTD |
PMID:25926378 |
|
NCBI chr16:33,986,265...34,024,228
Ensembl chr16:33,986,266...34,024,228
|
|
G |
Hsbp1 |
heat shock factor binding protein 1 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to HSBP1 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr19:47,401,039...47,405,373
Ensembl chr19:47,400,966...47,435,821
|
|
G |
Hscb |
HscB mitochondrial iron-sulfur cluster co-chaperone |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of HSCB mRNA |
CTD |
PMID:25926378 |
|
NCBI chr12:45,821,527...45,831,902
Ensembl chr12:45,821,555...45,831,909
|
|
G |
Hsp90aa1 |
heat shock protein 90 alpha family class A member 1 |
increases expression |
EXP |
Methylcholanthrene results in increased expression of HSP90AA1 mRNA |
CTD |
PMID:23273579 |
|
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of HSPA1A mRNA |
CTD |
PMID:23519560 |
|
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
multiple interactions increases expression |
EXP |
alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of HSPA8 mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
increases acetylation multiple interactions increases expression |
EXP |
Methylcholanthrene results in increased acetylation of ICAM1 promoter alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to ICAM1 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased acetylation of ICAM1 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of ICAM1 mRNA]; Methylcholanthrene promotes the reaction [AHR protein binds to ICAM1 promoter] |
CTD |
PMID:29094188 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Id2 |
inhibitor of DNA binding 2 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ID2 mRNA |
CTD |
PMID:20713471 PMID:23397585 |
|
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
|
|
G |
Id3 |
inhibitor of DNA binding 3 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ID3 mRNA |
CTD |
PMID:23397585 |
|
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to IDH2 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
|
|
G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of IDI1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
|
|
G |
Ier3 |
immediate early response 3 |
increases expression multiple interactions |
ISO |
Methylcholanthrene results in increased expression of IER3 mRNA Methylcholanthrene promotes the reaction [AHR protein binds to IER3 promoter] |
CTD |
PMID:20348232 PMID:20713471 PMID:22579512 |
|
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
|
|
G |
Ifi27 |
interferon, alpha-inducible protein 27 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of IFI27 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 6:122,590,461...122,596,996
Ensembl chr 6:122,590,472...122,779,294
|
|
G |
Ifi44 |
interferon-induced protein 44 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of IFI44 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 2:240,626,058...240,643,879
Ensembl chr 2:240,626,066...240,643,844
|
|
G |
Ifit2 |
interferon-induced protein with tetratricopeptide repeats 2 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of IFIT2 mRNA |
CTD |
PMID:29554273 |
|
NCBI chr 1:232,102,570...232,108,638
Ensembl chr 1:232,102,570...232,108,635
|
|
G |
Ifit3 |
interferon-induced protein with tetratricopeptide repeats 3 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of IFIT3 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
|
|
G |
Ifnb1 |
interferon beta 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of IFNB1 mRNA |
CTD |
PMID:29554273 |
|
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
|
|
G |
Igf2 |
insulin-like growth factor 2 |
increases acetylation multiple interactions increases expression increases methylation |
EXP |
Methylcholanthrene results in increased acetylation of IGF2 promoter alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to IGF2 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased acetylation of IGF2 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of IGF2 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of IGF2 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to IGF2 promoter] |
CTD |
PMID:29094188 |
|
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
|
|
G |
Igfbp6 |
insulin-like growth factor binding protein 6 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of IGFBP6 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 7:133,276,309...133,280,944
Ensembl chr 7:133,276,234...133,280,966
|
|
G |
Igfbpl1 |
insulin-like growth factor binding protein-like 1 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to IGFBPL1 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 5:60,076,428...60,091,833
Ensembl chr 5:60,076,429...60,091,833
|
|
G |
Il12a |
interleukin 12A |
increases expression |
ISO |
Methylcholanthrene results in increased expression of IL12A mRNA |
CTD |
PMID:14993811 |
|
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
|
|
G |
Il12rb1 |
interleukin 12 receptor subunit beta 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of IL12RB1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr16:18,620,228...18,633,207
Ensembl chr16:18,620,770...18,632,769
|
|
G |
Il18 |
interleukin 18 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of IL18 mRNA |
CTD |
PMID:14993811 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il18r1 |
interleukin 18 receptor 1 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of IL18R1 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 9:42,727,416...42,760,971
Ensembl chr 9:42,727,869...42,760,715
|
|
G |
Il18rap |
interleukin 18 receptor accessory protein |
increases expression |
ISO |
Methylcholanthrene results in increased expression of IL18RAP mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 9:42,768,112...42,800,964
Ensembl chr 9:42,768,220...42,800,959
|
|
G |
Il1a |
interleukin 1 alpha |
increases expression |
ISO |
Methylcholanthrene results in increased expression of IL1A mRNA |
CTD |
PMID:14993811 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
increases expression multiple interactions |
ISO |
Methylcholanthrene results in increased expression of IL1B mRNA [Methylcholanthrene results in increased activity of AHR protein] which results in increased expression of IL1B mRNA; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of IL1B mRNA] |
CTD |
PMID:14993811 PMID:35487396 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1rl1 |
interleukin 1 receptor-like 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of IL1RL1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
ISO |
Methylcholanthrene results in increased expression of IL6 mRNA [Methylcholanthrene co-treated with TNF protein] results in increased expression of IL6 mRNA |
CTD |
PMID:14993811 PMID:23396138 PMID:29554273 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il6st |
interleukin 6 cytokine family signal transducer |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of IL6ST mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
|
|
G |
Il7r |
interleukin 7 receptor |
multiple interactions increases expression |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of IL7R mRNA Methylcholanthrene results in increased expression of IL7R mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 2:58,452,393...58,477,757
Ensembl chr 2:58,454,217...58,477,757
|
|
G |
Immp2l |
inner mitochondrial membrane peptidase subunit 2 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of IMMP2L mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 6:58,070,035...58,970,165
Ensembl chr 6:58,070,283...58,969,840
|
|
G |
Inhbc |
inhibin subunit beta C |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to INHBC promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 7:63,184,141...63,197,630
Ensembl chr 7:63,184,142...63,197,630
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [Glucose results in increased secretion of INS protein alternative form] |
CTD |
PMID:31776611 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Iqgap3 |
IQ motif containing GTPase activating protein 3 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of IQGAP3 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 2:173,542,151...173,583,956
Ensembl chr 2:173,542,110...173,583,956
|
|
G |
Irf2bpl |
interferon regulatory factor 2 binding protein-like |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to IRF2BPL promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 6:106,527,179...106,531,294
Ensembl chr 6:106,528,053...106,530,401
|
|
G |
Irs1 |
insulin receptor substrate 1 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of IRS1 mRNA |
CTD |
PMID:29554273 |
|
NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122
|
|
G |
Isoc2b |
isochorismatase domain containing 2b |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to ISOC2 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 1:68,972,960...68,993,760
Ensembl chr 1:68,972,960...68,993,757
|
|
G |
Itga10 |
integrin subunit alpha 10 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ITGA10 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 2:184,182,869...184,202,172
Ensembl chr 2:184,182,869...184,202,172
|
|
G |
Itga7 |
integrin subunit alpha 7 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of ITGA7 mRNA |
CTD |
PMID:23519560 |
|
NCBI chr 7:1,360,125...1,388,886
Ensembl chr 7:1,359,940...1,388,450
|
|
G |
Itgb5 |
integrin subunit beta 5 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of ITGB5 mRNA |
CTD |
PMID:23397585 |
|
NCBI chr11:66,828,428...66,944,231
Ensembl chr11:66,829,285...66,944,472
|
|
G |
Itgb8 |
integrin subunit beta 8 |
decreases expression multiple interactions |
EXP |
Methylcholanthrene results in decreased expression of ITGB8 mRNA alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in decreased expression of ITGB8 mRNA] |
CTD |
PMID:29094188 |
|
NCBI chr 6:140,125,002...140,208,261
Ensembl chr 6:140,127,203...140,208,476
|
|
G |
Itgbl1 |
integrin subunit beta like 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of ITGBL1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr15:100,780,184...101,041,734
Ensembl chr15:100,780,184...101,041,733
|
|
G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
multiple interactions increases expression |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to ITPR1 promoter] Methylcholanthrene results in increased expression of ITPR1 mRNA |
CTD |
PMID:20348232 |
|
NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491
|
|
G |
Jag1 |
jagged canonical Notch ligand 1 |
decreases expression increases expression multiple interactions increases acetylation increases methylation |
ISO EXP |
Methylcholanthrene results in decreased expression of JAG1 mRNA Methylcholanthrene results in increased expression of JAG1 mRNA alpha-naphthoflavone inhibits the reaction [Methylcholanthrene promotes the reaction [AHR protein binds to JAG1 promoter]]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased acetylation of JAG1 promoter]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of JAG1 mRNA]; alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased methylation of JAG1 promoter]; Methylcholanthrene promotes the reaction [AHR protein binds to JAG1 promoter] |
CTD |
PMID:20713471 PMID:29094188 |
|
NCBI chr 3:124,406,783...124,442,220
Ensembl chr 3:124,406,794...124,442,209
|
|
G |
Jak2 |
Janus kinase 2 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of JAK2 mRNA |
CTD |
PMID:22978700 |
|
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Jph1 |
junctophilin 1 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to JPH1 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 5:2,030,227...2,137,171
Ensembl chr 5:2,030,281...2,125,284
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Methylcholanthrene results in increased expression of JUN mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Katnal2 |
katanin catalytic subunit A1 like 2 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to KATNAL2 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr18:70,531,759...70,607,886
Ensembl chr18:70,531,754...70,608,082
|
|
G |
Kcnk2 |
potassium two pore domain channel subfamily K member 2 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of KCNK2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr13:100,766,101...100,963,435
Ensembl chr13:100,766,113...100,963,435
|
|
G |
Kcnn4 |
potassium calcium-activated channel subfamily N member 4 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of KCNN4 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 1:79,956,380...79,974,354
Ensembl chr 1:79,959,322...79,974,340
|
|
G |
Kctd1 |
potassium channel tetramerization domain containing 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of KCTD1 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr18:6,122,390...6,316,434
Ensembl chr18:6,122,390...6,317,393
|
|
G |
Kctd16 |
potassium channel tetramerization domain containing 16 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to KCTD16 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr18:32,166,236...32,473,067
Ensembl chr18:32,166,861...32,491,749
|
|
G |
Kctd3 |
potassium channel tetramerization domain containing 3 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to KCTD3 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr13:100,510,193...100,548,765
Ensembl chr13:100,510,195...100,548,718
|
|
G |
Kctd5 |
potassium channel tetramerization domain containing 5 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of KCTD5 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr10:13,079,216...13,105,197
Ensembl chr10:13,079,214...13,105,209
|
|
G |
Kdr |
kinase insert domain receptor |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of KDR mRNA |
CTD |
PMID:25926378 |
|
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of KEAP1 mRNA |
CTD |
PMID:23712962 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Kif11 |
kinesin family member 11 |
increases expression multiple interactions |
ISO EXP |
Methylcholanthrene results in increased expression of KIF11 mRNA Methylcholanthrene inhibits the reaction [8-prenylnaringenin results in increased expression of KIF11 mRNA] |
CTD |
PMID:20713471 PMID:26372666 |
|
NCBI chr 1:235,124,371...235,176,760
Ensembl chr 1:235,124,316...235,176,766
|
|
G |
Kif18a |
kinesin family member 18A |
increases expression multiple interactions |
ISO EXP |
Methylcholanthrene results in increased expression of KIF18A mRNA Methylcholanthrene inhibits the reaction [8-prenylnaringenin results in increased expression of KIF18A mRNA] |
CTD |
PMID:20713471 PMID:26372666 |
|
NCBI chr 3:95,764,388...95,824,756
Ensembl chr 3:95,764,388...95,824,582
|
|
G |
Kif20a |
kinesin family member 20A |
increases expression |
ISO |
Methylcholanthrene results in increased expression of KIF20A mRNA |
CTD |
PMID:20713471 |
|
NCBI chr18:26,230,294...26,238,780
Ensembl chr18:26,230,230...26,238,780
|
|
G |
Kif22 |
kinesin family member 22 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of KIF22 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 1:181,635,347...181,650,351
Ensembl chr 1:181,635,183...181,650,401
|
|
G |
Kif23 |
kinesin family member 23 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of KIF23 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 8:62,397,908...62,425,162
Ensembl chr 8:62,397,948...62,425,072
|
|
G |
Kif2c |
kinesin family member 2C |
increases expression |
ISO EXP |
Methylcholanthrene results in increased expression of KIF2C mRNA |
CTD |
PMID:20713471 PMID:26372666 |
|
NCBI chr 5:130,637,347...130,662,680
Ensembl chr 5:130,637,347...130,662,637
|
|
G |
Kit |
KIT proto-oncogene receptor tyrosine kinase |
affects expression |
ISO |
Methylcholanthrene affects the expression of KIT mRNA |
CTD |
PMID:35487396 |
|
NCBI chr14:32,547,459...32,624,694
Ensembl chr14:32,548,877...32,624,652
|
|
G |
Kitlg |
KIT ligand |
increases expression |
ISO |
Methylcholanthrene results in increased expression of KITL mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
|
|
G |
Klf2 |
KLF transcription factor 2 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of KLF2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr16:17,521,107...17,523,739
Ensembl chr16:17,514,552...17,523,944
|
|
G |
Klf5 |
KLF transcription factor 5 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of KLF5 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr15:76,060,320...76,079,445
Ensembl chr15:76,064,258...76,079,445
|
|
G |
Klf9 |
KLF transcription factor 9 |
multiple interactions decreases expression |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to KLF9 promoter] Methylcholanthrene results in decreased expression of KLF9 mRNA |
CTD |
PMID:20348232 PMID:23397585 |
|
NCBI chr 1:220,700,108...220,725,110
Ensembl chr 1:220,700,108...220,725,037
|
|
G |
Kmt2e |
lysine methyltransferase 2E |
increases expression |
ISO |
Methylcholanthrene results in increased expression of KMT2E mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 4:11,658,218...11,727,373
Ensembl chr 4:11,658,979...11,727,373
|
|
G |
Kng1 |
kininogen 1 |
multiple interactions decreases expression |
ISO |
AHR protein promotes the reaction [Methylcholanthrene results in decreased expression of KNG1 mRNA]; AHR protein promotes the reaction [Methylcholanthrene results in decreased expression of KNG1 protein] Methylcholanthrene results in decreased expression of KNG1 mRNA; Methylcholanthrene results in decreased expression of KNG1 protein |
CTD |
PMID:11549291 |
|
NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
|
|
G |
Knstrn |
kinetochore-localized astrin/SPAG5 binding protein |
increases expression |
ISO |
Methylcholanthrene results in increased expression of KNSTRN mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 3:105,800,762...105,820,555
Ensembl chr 3:105,800,954...105,820,715
|
|
G |
Kntc1 |
kinetochore associated 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of KNTC1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr12:32,769,020...32,839,617
Ensembl chr12:32,769,020...32,839,561
|
|
G |
Kpna2 |
karyopherin subunit alpha 2 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of KPNA2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr10:91,933,951...91,946,115
Ensembl chr10:91,933,951...91,946,150
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
multiple interactions increases mutagenesis |
ISO |
Methylcholanthrene promotes the reaction [GATA6 protein binds to KRAS exon]; Methylcholanthrene promotes the reaction [NFYA protein binds to KRAS exon] Methylcholanthrene results in increased mutagenesis of KRAS gene |
CTD |
PMID:11195466 PMID:16271038 PMID:20101149 |
|
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Krt75 |
keratin 75 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to KRT75 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 7:132,687,101...132,697,360
Ensembl chr 7:132,688,237...132,697,345
|
|
G |
Lama4 |
laminin subunit alpha 4 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of LAMA4 mRNA |
CTD |
PMID:29554273 |
|
NCBI chr20:42,392,268...42,533,347
Ensembl chr20:42,392,268...42,533,347
|
|
G |
Lama5 |
laminin subunit alpha 5 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of LAMA5 mRNA |
CTD |
PMID:23519560 |
|
NCBI chr 3:167,270,296...167,318,370
Ensembl chr 3:167,270,296...167,318,451
|
|
G |
Lamc2 |
laminin subunit gamma 2 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of LAMC2 mRNA |
CTD |
PMID:23519560 |
|
NCBI chr13:65,284,664...65,344,164
Ensembl chr13:65,284,664...65,344,200
|
|
G |
Lcat |
lecithin cholesterol acyltransferase |
decreases expression |
EXP |
Methylcholanthrene results in decreased expression of LCAT mRNA |
CTD |
PMID:11328961 |
|
NCBI chr19:33,834,748...33,838,214
Ensembl chr19:33,834,403...33,838,231
|
|
G |
Ldlr |
low density lipoprotein receptor |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of LDLR mRNA |
CTD |
PMID:35487396 |
|
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Lef1 |
lymphoid enhancer binding factor 1 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of LEF1 mRNA |
CTD |
PMID:23519560 |
|
NCBI chr 2:219,666,549...219,779,815
Ensembl chr 2:219,666,592...219,779,794
|
|
G |
Lgals1 |
galectin 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of LGALS1 mRNA |
CTD |
PMID:22579512 |
|
NCBI chr 7:110,485,239...110,488,345
Ensembl chr 7:110,481,392...110,488,345
|
|
G |
Lgals2 |
galectin 2 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of LGALS2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 7:110,403,171...110,410,046
Ensembl chr 7:110,403,173...110,404,802
|
|
G |
Lgals3 |
galectin 3 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of LGALS3 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
|
|
G |
Lgals8 |
galectin 8 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to LGALS8 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr17:58,024,652...58,052,764
Ensembl chr17:58,028,105...58,052,764
|
|
G |
Lgi1 |
leucine-rich, glioma inactivated 1 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to LGI1 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 1:236,043,269...236,084,617
Ensembl chr 1:236,042,954...236,084,616
|
|
G |
Lif |
LIF, interleukin 6 family cytokine |
increases expression multiple interactions |
ISO |
Methylcholanthrene results in increased expression of LIF mRNA Methylcholanthrene promotes the reaction [AHR protein binds to LIF promoter] |
CTD |
PMID:20348232 PMID:20713471 |
|
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
|
|
G |
Lima1 |
LIM domain and actin binding 1 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to LIMA1 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 7:130,901,717...131,001,512
Ensembl chr 7:130,901,717...131,001,473
|
|
G |
Lmnb1 |
lamin B1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of LMNB1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
|
|
G |
Lmtk2 |
lemur tyrosine kinase 2 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in increased expression of LMTK2 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr12:10,426,772...10,508,750
Ensembl chr12:10,426,777...10,508,750
|
|
G |
Lox |
lysyl oxidase |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of LOX mRNA |
CTD |
PMID:20713471 |
|
NCBI chr18:45,964,544...45,977,431
Ensembl chr18:45,967,343...46,041,477
|
|
G |
Lrp11 |
LDL receptor related protein 11 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to LRP11 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 1:2,048,307...2,108,115
Ensembl chr 1:2,079,438...2,108,110
|
|
G |
Lrr1 |
leucine rich repeat protein 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of LRR1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 6:87,643,195...87,651,894
Ensembl chr 6:87,643,217...87,651,894
|
|
G |
Lrrc8d |
leucine rich repeat containing 8 VRAC subunit D |
increases expression |
ISO |
Methylcholanthrene results in increased expression of LRRC8D mRNA |
CTD |
PMID:20713471 |
|
NCBI chr14:4,029,971...4,134,922
Ensembl chr14:4,029,473...4,135,877
|
|
G |
Lsm4 |
LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated |
increases expression |
ISO |
Methylcholanthrene results in increased expression of LSM4 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr16:18,755,481...18,761,106
Ensembl chr16:18,755,484...18,760,926
|
|
G |
Lsm5 |
LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to LSM5 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 4:85,951,073...85,954,289
Ensembl chr 6:104,652,477...104,654,165 Ensembl chr 4:104,652,477...104,654,165
|
|
G |
Lsm6 |
LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated |
increases expression |
ISO |
Methylcholanthrene results in increased expression of LSM6 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr19:29,098,254...29,112,858
Ensembl chr13:42,114,032...42,116,484 Ensembl chr19:42,114,032...42,116,484
|
|
G |
Ltbp1 |
latent transforming growth factor beta binding protein 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of LTBP1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 6:20,029,629...20,425,339
Ensembl chr 6:20,029,629...20,425,349
|
|
G |
Lum |
lumican |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of LUM mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 7:32,358,990...32,365,794
Ensembl chr 7:32,358,614...32,365,793
|
|
G |
Ly6a |
lymphocyte antigen 6 family member A |
increases expression |
ISO |
Methylcholanthrene results in increased expression of LY6A mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 7:107,177,191...107,189,436
Ensembl chr 7:107,183,469...107,189,981
|
|
G |
Ly6e |
lymphocyte antigen 6 family member E |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to LY6E promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 7:106,935,530...106,939,689
Ensembl chr 7:106,935,761...106,939,689
|
|
G |
Mad1l1 |
mitotic arrest deficient 1 like 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of MAD1L1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr12:14,320,892...14,630,750
Ensembl chr12:14,320,892...14,630,703
|
|
G |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of MAGI1 mRNA |
CTD |
PMID:23519560 |
|
NCBI chr 4:126,205,663...126,811,354
Ensembl chr 4:126,206,816...126,811,691
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of MAP2K1 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Map2k3 |
mitogen activated protein kinase kinase 3 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of MAP2K3 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr10:45,608,145...45,629,492
Ensembl chr10:45,607,163...45,629,492
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of MAPK1 mRNA |
CTD |
PMID:23712962 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
Methylcholanthrene results in increased phosphorylation of and results in increased activity of MAPK8 protein |
CTD |
PMID:16619036 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapkap1 |
MAPK associated protein 1 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to MAPKAP1 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 3:17,715,813...17,918,387
Ensembl chr 3:17,715,834...17,918,384
|
|
G |
Marcks |
myristoylated alanine rich protein kinase C substrate |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of MARCKS mRNA |
CTD |
PMID:20713471 |
|
NCBI chr20:40,685,315...40,691,012
Ensembl chr20:40,685,315...40,691,012
|
|
G |
Mastl |
microtubule associated serine/threonine kinase-like |
increases expression |
ISO |
Methylcholanthrene results in increased expression of MASTL mRNA |
CTD |
PMID:20713471 |
|
NCBI chr17:85,250,512...85,287,479
Ensembl chr17:85,251,997...85,287,353
|
|
G |
Mat1a |
methionine adenosyltransferase 1A |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of MAT1A mRNA |
CTD |
PMID:22100608 |
|
NCBI chr16:16,983,084...17,001,284
Ensembl chr16:16,983,022...17,001,274
|
|
G |
Matn2 |
matrilin 2 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of MATN2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 7:65,494,996...65,644,613
Ensembl chr 7:65,494,834...65,645,113
|
|
G |
Mbnl1 |
muscleblind-like splicing regulator 1 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to MBNL1 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 2:144,639,819...144,814,395
Ensembl chr 2:144,670,285...144,814,368
|
|
G |
Mcm10 |
minichromosome maintenance 10 replication initiation factor |
increases expression |
ISO |
Methylcholanthrene results in increased expression of MCM10 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr17:73,263,788...73,288,346
Ensembl chr17:73,266,095...73,287,364
|
|
G |
Mcm3 |
minichromosome maintenance complex component 3 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of MCM3 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314
|
|
G |
Mcm4 |
minichromosome maintenance complex component 4 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of MCM4 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr11:85,258,443...85,272,144
Ensembl chr11:85,258,443...85,272,144
|
|
G |
Mcm5 |
minichromosome maintenance complex component 5 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of MCM5 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr19:13,483,030...13,504,389
Ensembl chr19:13,483,066...13,504,389
|
|
G |
Mcm6 |
minichromosome maintenance complex component 6 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of MCM6 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr13:39,826,745...39,851,937
Ensembl chr13:39,826,763...39,851,960
|
|
G |
Med13l |
mediator complex subunit 13L |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to MED13L promoter] |
CTD |
PMID:20348232 |
|
NCBI chr12:37,807,596...38,004,886
Ensembl chr12:37,808,285...38,004,473
|
|
G |
Melk |
maternal embryonic leucine zipper kinase |
increases expression |
ISO |
Methylcholanthrene results in increased expression of MELK mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 5:58,540,393...58,600,562
Ensembl chr 5:58,540,449...58,600,937
|
|
G |
Mesp1 |
mesoderm posterior bHLH transcription factor 1 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to MESP1 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 1:133,738,357...133,739,875
Ensembl chr 1:133,738,357...133,739,875
|
|
G |
Mfap3l |
microfibril associated protein 3 like |
increases expression |
ISO |
Methylcholanthrene results in increased expression of MFAP3L mRNA |
CTD |
PMID:20713471 |
|
NCBI chr16:29,411,643...29,454,665
Ensembl chr16:29,415,849...29,430,863
|
|
G |
Mgst2 |
microsomal glutathione S-transferase 2 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to MGST2 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 2:135,679,524...135,715,828
Ensembl chr 2:135,693,557...135,715,828
|
|
G |
Mid1 |
midline 1 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of MID1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr X:24,116,674...24,491,205
Ensembl chr X:24,120,293...24,248,353
|
|
G |
Mideas |
mitotic deacetylase associated SANT domain protein |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to MIDEAS promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 6:103,784,779...103,854,470
Ensembl chr 6:103,787,873...103,829,178
|
|
G |
Mir101-2 |
microRNA 101-2 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in increased expression of MIR101B mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 1:226,860,371...226,860,467
Ensembl chr 1:226,860,371...226,860,467
|
|
G |
Mir122 |
microRNA 122 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in increased expression of MIR122 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr18:58,758,703...58,758,787
|
|
G |
Mir130a |
microRNA 130a |
affects expression |
ISO |
Methylcholanthrene affects the expression of MIR130A mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 3:69,822,542...69,822,629
Ensembl chr 3:69,822,542...69,822,629
|
|
G |
Mir130b |
microRNA 130b |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of MIR130B mRNA |
CTD |
PMID:25926378 |
|
NCBI chr11:83,880,163...83,880,244
Ensembl chr11:83,880,163...83,880,244
|
|
G |
Mir144 |
microRNA 144 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in increased expression of MIR144 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr10:62,961,348...62,961,430
Ensembl chr10:62,961,348...62,961,430
|
|
G |
Mir145 |
microRNA 145 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of MIR145A mRNA |
CTD |
PMID:25926378 |
|
NCBI chr18:55,099,640...55,099,727
Ensembl chr18:55,099,640...55,099,727
|
|
G |
Mir191 |
microRNA 191 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of MIR191 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 8:109,264,098...109,264,188
|
|
G |
Mir19a |
microRNA 19a |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in increased expression of MIR19A mRNA |
CTD |
PMID:25926378 |
|
NCBI chr15:92,180,912...92,180,993
Ensembl chr15:92,180,912...92,180,993
|
|
G |
Mir206 |
microRNA 206 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of MIR206 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 9:23,094,249...23,094,332
Ensembl chr 9:23,094,249...23,094,332
|
|
G |
Mir210 |
microRNA 210 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in increased expression of MIR210 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 1:196,326,343...196,326,452
Ensembl chr 1:196,326,337...196,326,454
|
|
G |
Mir211 |
microRNA 211 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of MIR211 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 1:117,777,539...117,777,644
Ensembl chr 1:117,777,539...117,777,644
|
|
G |
Mir32 |
microRNA 32 |
decreases expression multiple interactions |
ISO |
Methylcholanthrene results in decreased expression of MIR32 mRNA [Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of MIR32 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 5:71,596,083...71,596,152
Ensembl chr 5:71,596,083...71,596,152
|
|
G |
Mir340-1 |
microRNA 340-1 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in increased expression of MIR340 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr10:34,393,568...34,393,665
Ensembl chr10:34,393,568...34,393,665
|
|
G |
Mir345 |
microRNA 345 |
affects expression multiple interactions |
ISO |
Methylcholanthrene affects the expression of MIR345 mRNA [Methylcholanthrene co-treated with Nanotubes, Carbon] results in increased expression of MIR345 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 6:127,754,027...127,754,122
Ensembl chr 6:127,754,027...127,754,122
|
|
G |
Mir3545 |
microRNA 3545 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of MIR203 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 6:131,199,542...131,199,656
Ensembl chr 6:131,199,542...131,199,656
|
|
G |
Mir425 |
microRNA 425 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of MIR425 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 8:109,264,555...109,264,637
Ensembl chr 8:109,264,555...109,264,637
|
|
G |
Mir449a |
microRNA 449a |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of MIR449A mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 2:44,670,714...44,670,804
Ensembl chr 2:44,670,714...44,670,804
|
|
G |
Mir497 |
microRNA 497 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of MIR497 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr10:54,951,514...54,951,582
Ensembl chr10:54,951,505...54,951,584
|
|
G |
Mir92a2 |
microRNA 92a-2 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of MIR92-2 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr X:132,421,942...132,422,033
Ensembl chr X:132,421,942...132,422,033
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
increases expression multiple interactions |
ISO EXP |
Methylcholanthrene results in increased expression of MKI67 mRNA Methylcholanthrene inhibits the reaction [Estradiol results in increased expression of MKI67 mRNA]; Methylcholanthrene inhibits the reaction [Estradiol results in increased expression of MKI67 protein] |
CTD |
PMID:20713471 PMID:26372666 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mllt6 |
MLLT6, PHD finger containing |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to MLLT6 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr10:82,657,258...82,678,899
Ensembl chr10:82,656,872...82,676,073
|
|
G |
Mlph |
melanophilin |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to MLPH promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 9:91,507,410...91,542,984
Ensembl chr 9:91,507,591...91,542,983
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of MMP1 mRNA |
CTD |
PMID:29554273 |
|
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mmp13 |
matrix metallopeptidase 13 |
increases expression decreases expression |
ISO |
Methylcholanthrene results in increased expression of MMP13 mRNA Methylcholanthrene results in decreased expression of MMP13 mRNA |
CTD |
PMID:20713471 PMID:29554273 |
|
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
EXP |
[Methylcholanthrene co-treated with Diethylnitrosamine] results in increased expression of MMP2 mRNA; [Methylcholanthrene co-treated with Diethylnitrosamine] results in increased expression of MMP2 protein |
CTD |
PMID:12015029 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of MMP3 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of MMP9 mRNA Methylcholanthrene results in decreased expression of MMP9 mRNA |
CTD |
PMID:23519560 PMID:29554273 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpi |
mannose phosphate isomerase |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to MPI promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 8:57,947,883...57,956,205
Ensembl chr 8:57,947,893...57,956,150
|
|
G |
Mpl |
MPL proto-oncogene, thrombopoietin receptor |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of MPL mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 5:131,973,895...131,987,472
Ensembl chr 5:131,973,895...131,986,797
|
|
G |
Mrtfb |
myocardin related transcription factor B |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to MRTFB promoter] |
CTD |
PMID:20348232 |
|
NCBI chr10:1,116,315...1,278,106
Ensembl chr10:1,116,310...1,277,897
|
|
G |
Ms4a7 |
membrane spanning 4-domains A7 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to MS4A7 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 1:207,969,117...207,984,743
Ensembl chr 1:207,968,761...207,983,260
|
|
G |
Msh4 |
mutS homolog 4 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of MSH4 mRNA |
CTD |
PMID:35487396 |
|
NCBI chr 2:242,785,392...242,844,609
Ensembl chr 2:242,792,661...242,843,487
|
|
G |
Msh5 |
mutS homolog 5 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of MSH5 mRNA |
CTD |
PMID:35487396 |
|
NCBI chr20:3,773,867...3,793,337
Ensembl chr20:3,776,942...3,793,336
|
|
G |
Msln |
mesothelin |
increases expression |
ISO |
Methylcholanthrene results in increased expression of MSLN mRNA |
CTD |
PMID:20713471 |
|
NCBI chr10:14,771,946...14,781,382
Ensembl chr10:14,771,961...14,777,643
|
|
G |
Msmb |
microseminoprotein, beta |
multiple interactions affects binding increases expression |
ISO EXP |
Methylcholanthrene promotes the reaction [AHR protein binds to MSMB promoter] Methylcholanthrene binds to MSMB protein Methylcholanthrene results in increased expression of MSMB mRNA |
CTD |
PMID:3940634 PMID:20348232 |
|
NCBI chr16:7,366,536...7,387,124
Ensembl chr16:7,366,536...7,387,123
|
|
G |
Msmo1 |
methylsterol monooxygenase 1 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of MSMO1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr16:24,980,680...24,997,927
Ensembl chr16:24,980,697...24,998,016
|
|
G |
Mt2A |
metallothionein 2A |
multiple interactions increases expression |
ISO |
AHR protein affects the reaction [Methylcholanthrene results in increased expression of MT2A mRNA]; Dexamethasone promotes the reaction [Methylcholanthrene results in increased expression of MT2A mRNA]; Methylcholanthrene promotes the reaction [Dexamethasone results in increased expression of MT2A mRNA]; NR3C1 protein affects the reaction [Dexamethasone promotes the reaction [Methylcholanthrene results in increased expression of MT2A mRNA]]; NR3C1 protein affects the reaction [Methylcholanthrene promotes the reaction [Dexamethasone results in increased expression of MT2A mRNA]]; NR3C1 protein affects the reaction [Methylcholanthrene results in increased expression of MT2A mRNA] |
CTD |
PMID:23994556 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mtcl3 |
MTCL family member 3 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to MTCL3 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 1:28,629,036...28,701,416
Ensembl chr 1:28,620,293...28,701,796
|
|
G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in increased expression of MTHFD2 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
|
|
G |
Mx2 |
MX dynamin like GTPase 2 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of MX2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr11:36,905,698...36,936,308
Ensembl chr11:36,906,111...36,930,342
|
|
G |
Mybl1 |
MYB proto-oncogene like 1 |
affects expression |
ISO |
Methylcholanthrene affects the expression of MYBL1 mRNA |
CTD |
PMID:35487396 |
|
NCBI chr 5:9,582,905...9,618,179
Ensembl chr 5:9,582,934...9,618,183
|
|
G |
Mybl2 |
MYB proto-oncogene like 2 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of MYBL2 mRNA |
CTD |
PMID:35487396 |
|
NCBI chr 3:151,705,254...151,733,714
Ensembl chr 3:151,705,288...151,733,708
|
|
G |
Myh7 |
myosin heavy chain 7 |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Nanotubes, Carbon] results in increased expression of MYH7 mRNA |
CTD |
PMID:25926378 |
|
NCBI chr15:28,446,550...28,469,888
Ensembl chr15:28,446,550...28,468,217
|
|
G |
Myl9 |
myosin light chain 9 |
decreases expression multiple interactions |
ISO |
Methylcholanthrene results in decreased expression of MYL9 mRNA [Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of MYL9 mRNA |
CTD |
PMID:20713471 PMID:25926378 |
|
NCBI chr 3:145,281,943...145,288,333
Ensembl chr 3:145,281,937...145,288,333
|
|
G |
Mylk |
myosin light chain kinase |
multiple interactions |
ISO |
[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of MYLK mRNA |
CTD |
PMID:23519560 |
|
NCBI chr11:65,783,008...66,030,239
Ensembl chr11:65,783,008...66,030,261
|
|
G |
Myo1d |
myosin ID |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of MYO1D mRNA |
CTD |
PMID:20713471 |
|
NCBI chr10:65,489,153...65,765,812
Ensembl chr10:65,489,154...65,766,349
|
|
G |
Myo7a |
myosin VIIA |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of MYO7A mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 1:152,342,611...152,414,171
Ensembl chr 1:152,344,448...152,414,157
|
|
G |
Myof |
myoferlin |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to MYOF promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 1:235,673,666...235,822,413
Ensembl chr 1:235,673,666...235,822,334
|
|
G |
Myom2 |
myomesin 2 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to MYOM2 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr16:74,520,148...74,592,658
Ensembl chr16:74,520,157...74,592,772
|
|
G |
Nasp |
nuclear autoantigenic sperm protein |
increases expression |
ISO |
Methylcholanthrene results in increased expression of NASP mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 5:130,057,363...130,083,003
Ensembl chr 5:130,057,363...130,082,928
|
|
G |
Ncam1 |
neural cell adhesion molecule 1 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of NCAM1 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 8:49,865,629...50,165,687
Ensembl chr 8:49,865,633...50,166,014
|
|
G |
Ncapg2 |
non-SMC condensin II complex, subunit G2 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of NCAPG2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 6:137,342,449...137,418,083
Ensembl chr 6:137,342,943...137,415,159
|
|
G |
Ncaph |
non-SMC condensin I complex, subunit H |
increases expression |
ISO |
Methylcholanthrene results in increased expression of NCAPH mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 3:114,371,937...114,399,178
Ensembl chr 3:114,371,941...114,399,180
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of NCF1 mRNA |
CTD |
PMID:19559082 |
|
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
|
|
G |
Nck2 |
NCK adaptor protein 2 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of NCK2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr 9:45,713,979...45,840,330
Ensembl chr 9:45,714,883...45,840,307
|
|
G |
Ndc80 |
NDC80 kinetochore complex component |
decreases expression increases expression |
ISO |
Methylcholanthrene results in decreased expression of NDC80 mRNA Methylcholanthrene results in increased expression of NDC80 mRNA |
CTD |
PMID:20713471 PMID:22579512 |
|
NCBI chr 9:111,407,191...111,440,921
Ensembl chr 9:111,407,191...111,440,924
|
|
G |
Ndrg4 |
NDRG family member 4 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of NDRG4 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr19:9,351,408...9,387,398
Ensembl chr19:9,351,404...9,386,914
|
|
G |
Ndst1 |
N-deacetylase and N-sulfotransferase 1 |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to NDST1 promoter] |
CTD |
PMID:20348232 |
|
NCBI chr18:54,136,887...54,199,545
Ensembl chr18:54,140,779...54,178,191
|
|
G |
Nedd9 |
neural precursor cell expressed, developmentally down-regulated 9 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of NEDD9 mRNA |
CTD |
PMID:16619036 |
|
NCBI chr17:23,289,793...23,468,026
Ensembl chr17:23,282,326...23,468,019
|
|
G |
Nek2 |
NIMA-related kinase 2 |
increases expression |
ISO |
Methylcholanthrene results in increased expression of NEK2 mRNA |
CTD |
PMID:20713471 |
|
NCBI chr13:103,405,818...103,419,063
Ensembl chr13:103,405,819...103,419,051
|
|
G |
Nelfcd |
negative elongation factor complex member C/D |
multiple interactions |
ISO |
Methylcholanthrene promotes the reaction [AHR protein binds to NELFCD promoter] |
CTD |
PMID:20348232 |
|
NCBI chr 3:163,213,765...163,224,886
Ensembl chr 3:163,213,762...163,224,884
|
|
G |
Nfatc2 |
nuclear factor of activated T-cells 2 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of NFATC2 mRNA |
CTD |
PMID:29554273 |
|
NCBI chr 3:157,195,970...157,328,640
Ensembl chr 3:157,198,872...157,328,325
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
increases expression multiple interactions |
ISO |
Methylcholanthrene results in increased expression of NFE2L2 mRNA; Methylcholanthrene results in increased expression of NFE2L2 protein Methylcholanthrene promotes the reaction [AHR protein binds to NFE2L2 promoter] NFE2L2 protein affects the reaction [Methylcholanthrene results in increased expression of PSMB5 mRNA] |
CTD |
PMID:16723119 PMID:20348232 PMID:20713471 PMID:23712962 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
increases expression |
ISO |
Methylcholanthrene results in increased expression of NFKBIA mRNA |
CTD |
PMID:29554273 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nfkbiz |
NFKB inhibitor zeta |
increases expression |
ISO |
Methylcholanthrene results in increased expression of NFKBIZ mRNA |
CTD |
PMID:20713471 |
|
NCBI chr11:44,782,676...44,810,722
Ensembl chr11:44,782,676...44,810,723
|
|
G |
Nfya |
nuclear transcription factor Y subunit alpha |
multiple interactions increases activity |
ISO |
Methylcholanthrene promotes the reaction [NFYA protein binds to KRAS exon] Methylcholanthrene results in increased activity of NFYA protein |
CTD |
PMID:16271038 |
|
NCBI chr 9:12,587,437...12,613,911
Ensembl chr 9:12,586,259...12,613,898
|
|
G |
Ngf |
nerve growth factor |
increases expression multiple interactions |
ISO |
Methylcholanthrene results in increased expression of NGF mRNA [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of NGF mRNA |
CTD |
PMID:20713471 PMID:23519560 |
|
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
|
|
G |
Nherf2 |
NHERF family PDZ scaffold protein 2 |
decreases expression |
ISO |
Methylcholanthrene results in decreased expression of NHERF2 mRNA |
| |